A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy

Oliver C. Watkinsa Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

https://orcid.org/0000-0001-8202-6412

Hannah E. J. Yongb Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Singapore, Singapore

https://orcid.org/0000-0002-8814-752X

Neha Sharmaa Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

https://orcid.org/0000-0002-4287-5994

Shiao-Yng Chana Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore;b Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Singapore, SingaporeCorrespondence[email protected]

https://orcid.org/0000-0002-3530-3023

References

Adams, R. H., A. Porras, G. Alonso, M. Jones, K. Vintersten, S. Panelli, A. Valladares, L. Perez, R. Klein, and A. R. Nebreda. 2000. Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development. Molecular Cell 6 (1):109–116. doi: 10.1016/S1097-2765(05)00014-6.
PubMed Web of Science ®Google Scholar
Afroze, S. H., R. R. Kalagiri, M. Reyes, J. D. Zimmerman, M. R. Beeram, N. Drever, D. C. Zawieja, T. J. Kuehl, and M. N. Uddin. 2016. Apoptotic and stress signaling markers are augmented in preeclamptic placenta and umbilical cord. BBA Clinical 6:25–30. doi: 10.1016/j.bbacli.2016.05.003.
PubMed Web of Science ®Google Scholar
Alvarez, J., J. Sanchez-Arias, A. Guadano, F. Estevez, I. Varela, J. Feliu, and J. Mato. 1991. Transport in isolated rat hepatocytes of the phospho-oligosaccharide that mimics insulin action. Effects of adrenalectomy and glucocorticoid treatment. Biochemical Journal 274 (2):369–74. doi: 10.1042/bj2740369.
PubMedGoogle Scholar
Amaefule, C. E., Z. Drymoussi, J. Dodds, L. Sweeney, E. Pizzo, J. Daru, J. Robson, L. Poston, A. Khalil, J. Myers, et al. 2018. Effectiveness and acceptability of myo-inositol nutritional supplement in the prevention of gestational diabetes (EMmY): A protocol for a randomised, placebo-controlled, double-blind pilot trial. BMJ Open 8 (9):e022831., doi: 10.1136/bmjopen-2018-022831.
PubMed Web of Science ®Google Scholar
Andersen, D., and B. Holub. 1976. The influence of dietary inositol on glyceride composition and synthesis in livers of rats fed different fats. The Journal of Nutrition 106 (4):529–36. doi: 10.1093/jn/106.4.529.
PubMed Web of Science ®Google Scholar
Andersen, D., and B. Holub. 1980. Myo-inositol-responsive liver lipid accumulation in the rat. The Journal of Nutrition 110 (3):488–95. doi: 10.1093/jn/110.3.488.
PubMed Web of Science ®Google Scholar
Andersen, D., and B. Holub. 1980. The relative response of hepatic lipids in the rat to graded levels of dietary myo-inositol and other lipotropes. The Journal of Nutrition 110 (3):496–504. doi: 10.1093/jn/110.3.496.
PubMed Web of Science ®Google Scholar
Anderson, R. G., B. A. Kamen, K. G. Rothberg, and S. W. Lacey. 1992. Potocytosis: Sequestration and transport of small molecules by caveolae. Science255 (5043):410–412. doi: 10.1126/science.1310359.
PubMed Web of Science ®Google Scholar
Antonsson, B. E. 1994. Purification and characterization of phosphatidylinositol synthase from human placenta. Biochemical Journal 297 (3):517–522. doi: 10.1042/bj2970517.
PubMedGoogle Scholar
Antony, P. J., G. R. Gandhi, A. Stalin, K. Balakrishna, E. Toppo, K. Sivasankaran, S. Ignacimuthu, and N. A. Al-Dhabi. 2017. Myoinositol ameliorates high-fat diet and streptozotocin-induced diabetes in rats through promoting insulin receptor signaling. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 88:1098–113. doi: 10.1016/j.biopha.2017.01.170.
PubMed Web of Science ®Google Scholar
Aouameur, R., S. Da Cal, P. Bissonnette, M. J. Coady, and J.-Y. Lapointe. 2007. SMIT2 mediates all myo-inositol uptake in apical membranes of rat small intestine. American Journal of Physiology. Gastrointestinal and Liver Physiology 293 (6):G1300–G1307. doi: 10.1152/ajpgi.00422.2007.
PubMed Web of Science ®Google Scholar
Arner, R. J., K. S. Prabhu, J. T. Thompson, G. R. Hildenbrandt, A. D. Liken, and C. C. Reddy. 2001. Myo-Inositol oxygenase: Molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol. The Biochemical Journal 360 (Pt 2):313–320. doi: 10.1042/bj3600313.
PubMedGoogle Scholar
Arner, R. J., K. S. Prabhu, V. Krishnan, M. C. Johnson, and C. C. Reddy. 2006. Expression of myo-inositol oxygenase in tissues susceptible to diabetic complications. Biochemical and Biophysical Research Communications 339 (3):816–820. doi: 10.1016/j.bbrc.2005.11.090.
PubMed Web of Science ®Google Scholar
Artini, P. G., O. Di Berardino, F. Papini, A. Genazzani, G. Simi, M. Ruggiero, and V. Cela. 2013. Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study. Gynecological Endocrinology 29 (4):375–379. doi: 10.3109/09513590.2012.743020.
PubMed Web of Science ®Google Scholar
Ashcroft, F. M., M. Rohm, A. Clark, and M. F. Brereton. 2017. Is type 2 diabetes a glycogen storage disease of pancreatic β cells? Cell Metabolism 26 (1):17–23. doi: 10.1016/j.cmet.2017.05.014.
PubMed Web of Science ®Google Scholar
Asplin, I., G. Galasko, and J. Larner. 1993. Chiro-inositol deficiency and insulin resistance: A comparison of the chiro-inositol-and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proceedings of the National Academy of Sciences 90 (13):5924–8. doi: 10.1073/pnas.90.13.5924.
PubMed Web of Science ®Google Scholar
Baillargeon, J. P., E. Diamanti-Kandarakis, R. E. Ostlund, T. Apridonidze, M. J. Iuorno, and J. E. Nestler. 2006. Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care 29 (2):300–5. doi: 10.2337/diacare.29.02.06.dc05-1070.
PubMed Web of Science ®Google Scholar
Baillargeon, J.-P., J. E. Nestler, R. E. Ostlund, T. Apridonidze, and E. Diamanti-Kandarakis. 2008. Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. Human Reproduction 23 (6):1439–46. doi: 10.1093/humrep/den097.
PubMed Web of Science ®Google Scholar
Baillargeon, J.-P., M. J. Iuorno, D. J. Jakubowicz, T. Apridonidze, N. He, and J. E. Nestler. 2004. Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 89 (1):242–9. doi: 10.1210/jc.2003-030437.
PubMed Web of Science ®Google Scholar
Baillargeon, J. P., M. J. Iuorno, T. Apridonidze, and J. E. Nestler. 2010. Uncoupling between insulin and release of a D-chiro-inositol–containing inositolphosphoglycan mediator of insulin action in obese women with polycystic ovary syndrome. Metabolic Syndrome and Related Disorders 8 (2):127–36. doi: 10.1089/met.2009.0052.
PubMed Web of Science ®Google Scholar
Baker, L., R. Piddington, A. Goldman, J. Egler, and J. Moehring. 1990. Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos. Diabetologia 33 (10):593–596. doi: 10.1007/BF00400202.
PubMed Web of Science ®Google Scholar
Balla, T. 2013. Phosphoinositides: Tiny lipids with giant impact on cell regulation. Physiological Reviews 93 (3):1019–137. doi: 10.1152/physrev.00028.2012.
PubMed Web of Science ®Google Scholar
Barberini, L., A. Noto, C. Fattuoni, D. Grapov, A. Casanova, G. Fenu, M. Gaviano, R. Carboni, G. Ottonello, M. Crisafulli, et al. 2014. Urinary metabolomics (GC-MS) reveals that low and high birth weight infants share elevated inositol concentrations at birth. The Journal of Maternal-Fetal & Neonatal Medicine 27 (sup2):20–26., doi: 10.3109/14767058.2014.954786.
PubMed Web of Science ®Google Scholar
Barker, C. J., and P.-O. Berggren. 2013. New horizons in cellular regulation by inositol polyphosphates: Insights from the pancreatic β-cell. Pharmacological Reviews 65 (2):641–69. doi: 10.1124/pr.112.006775.
PubMed Web of Science ®Google Scholar
Barker, D. 2004. The developmental origins of adult disease. Journal of the American College of Nutrition 23 (sup6):588S–595S. doi: 10.1080/07315724.2004.10719428.
PubMed Web of Science ®Google Scholar
Battaglia, F. C., G. Meschia, J. N. Blechner, and D. H. Barron. 1961. The free myo‐inositol concentration of adult and fetal tissues of several species. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences 46:188–193. doi: 10.1113/expphysiol.1961.sp001532.
PubMedGoogle Scholar
Baumann, M. U., H. Schneider, A. Malek, V. Palta, D. V. Surbek, R. Sager, S. Zamudio, and N. P. Illsley. 2014. Regulation of human trophoblast GLUT1 glucose transporter by insulin-like growth factor I (IGF-I). PLoS One 9 (8):e106037. doi: 10.1371/journal.pone.0106037.
PubMed Web of Science ®Google Scholar
Bayon, Y., M. Croset, V. Chirouze, J. Tayot, and M. Lagarde. 1993. Phospholipid molecular species from human placenta lipids. Lipids 28 (7):631–636. doi: 10.1007/BF02536058.
PubMed Web of Science ®Google Scholar
Beach, D. C., and P. K. Flick. 1982. Early effect of myo-inositol deficiency on fatty acid synthetic enzymes of rat liver. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 711 (3):452–9. doi: 10.1016/0005-2760(82)90059-5.
PubMedGoogle Scholar
Behuria, B.,. S. Ghimere, S. Choudhary, M. Agrawal, R. P. Bodroth, and T. V. G. Rao. 2018. Possible enhancement of phosphatidyl inositol (PI) depends on its metabolic pathway components as second messengers: Evidence from the growth and pi levels of normal, PI grown, and UV exposed Saccharomyces cerevisiae. Global Journal of Biology. Agriculture & Health Sciences 7:26–31.
Google Scholar
Bellamy, L., J. P. Casas, A. D. Hingorani, and D. Williams. 2009. Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. The Lancet 373 (9677):1773–1779. doi: 10.1016/S0140-6736(09)60731-5.
PubMed Web of Science ®Google Scholar
Berridge, M. J. 2009. Inositol trisphosphate and calcium signalling mechanisms. Biochimica et Biophysica Acta (Bba) - Molecular Cell Research 1793 (6):933–40. doi: 10.1016/j.bbamcr.2008.10.005.
PubMed Web of Science ®Google Scholar
Berridge, M. J., and R. F. Irvine. 1989. Inositol phosphates and cell signalling. Nature 341 (6239):197–205. doi: 10.1038/341197a0.
PubMed Web of Science ®Google Scholar
Berry, G. T., J. J. Mallee, H. M. Kwon, J. S. Rim, W. R. Mulla, M. Muenke, and N. B. Spinner. 1995. The human osmoregulatory Na+/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21. Genomics 25 (2):507–513. doi: 10.1016/0888-7543(95)80052-N.
PubMed Web of Science ®Google Scholar
Berry, G. T., Z. J. Wang, S. F. Dreha, B. M. Finucane, and R. A. Zimmerman. 1999. In vivo brain myo-inositol levels in children with Down syndrome. The Journal of Pediatrics 135 (1):94–97. doi: 10.1016/S0022-3476(99)70334-3.
PubMed Web of Science ®Google Scholar
Bersudsky, Y., H. Einat, Z. Stahl, and R. H. Belmaker. 1999. Epi-inositol and inositol depletion: Two new treatment approaches in affective disorder. Current Psychiatry Reports 1 (2):141–147. doi: 10.1007/s11920-999-0023-z.
PubMedGoogle Scholar
Best, C., C. Lucas, J. M. Patterson, and J. H. Ridout. 1946. The influence of biotin upon the relative lipotropic effects of choline and inositol. The Biochemical Journal 40 (3):368–73.
Web of Science ®Google Scholar
Bevilacqua, A., G. Carlomagno, S. Gerli, M. Montanino Oliva, P. Devroey, A. Lanzone, C. Soulange, F. Facchinetti, G. Carlo Di Renzo, M. Bizzarri, et al. 2015. Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology–assisted reproduction technology. Gynecological Endocrinology 31 (6):441–6. doi: 10.3109/09513590.2015.1006616.
PubMed Web of Science ®Google Scholar
Bitsanis, D., M. A. Crawford, T. Moodley, H. Holmsen, K. Ghebremeskel, and O. Djahanbakhch. 2005. Arachidonic acid predominates in the membrane phosphoglycerides of the early and term human placenta. The Journal of Nutrition 135 (11):2566–71. doi: 10.1093/jn/135.11.2566.
PubMed Web of Science ®Google Scholar
Bizzarri, M., and G. Carlomagno. 2014. Inositol: History of an effective therapy for polycystic ovary syndrome. European Review for Medical and Pharmacological Sciences 18 (13):1896–903.
PubMed Web of Science ®Google Scholar
Blazer-Yost, B. L., and C. Nofziger. 2005. Phosphoinositide lipid second messengers: New paradigms for transepithelial signal transduction. Pflugers Archiv: European Journal of Physiology 450 (2):75–82. doi: 10.1007/s00424-004-1371-5.
PubMed Web of Science ®Google Scholar
Boone, D. L., W. D. Currie, and P. C. K. Leung. 1993. Arachidonic acid and cell signalling in the ovary and placenta. Prostaglandins, Leukotrienes and Essential Fatty Acids 48 (1):79–87. doi: 10.1016/0952-3278(93)90013-M.
PubMed Web of Science ®Google Scholar
Bourgeois, F., M. J. Coady, and J.-Y. Lapointe. 2005. Determination of transport stoichiometry for two cation-coupled myo-inositol cotransporters: SMIT2 and HMIT. The Journal of Physiology 563 (Pt 2):333–343. doi: 10.1113/jphysiol.2004.076679.
PubMed Web of Science ®Google Scholar
Brancho, D., N. Tanaka, A. Jaeschke, J.-J. Ventura, N. Kelkar, Y. Tanaka, M. Kyuuma, T. Takeshita, R. A. Flavell, and R. J. Davis. 2003. Mechanism of p38 MAP kinase activation in vivo. Genes & Development 17 (16):1969–1978. doi: 10.1101/gad.1107303.
PubMed Web of Science ®Google Scholar
Brautigan, D. L., M. Brown, S. Grindrod, G. Chinigo, A. Kruszewski, S. M. Lukasik, J. H. Bushweller, M. Horal, S. Keller, S. Tamura, et al. 2005. Allosteric activation of protein phosphatase 2C by d-chiro-inositol − galactosamine, a putative mediator mimetic of insulin action. Biochemistry 44 (33):11067–73. doi: 10.1021/bi0508845.
PubMed Web of Science ®Google Scholar
Brown, J., J. Crawford Tineke, and J. Alsweiler. 2015. Myo-inositol for preventing gestational diabetes – planning of reveiw. Cochrane Database Syst Rev 4
Google Scholar
Brusati, V., M. Jóźwik, M. Jóźwik, C. Teng, C. Paolini, A. M. Marconi, and F. C. Battaglia. 2005. Fetal and maternal non-glucose carbohydrates and polyols concentrations in normal human pregnancies at term. Pediatric Research 58 (4):700–704. doi: 10.1203/01.PDR.0000180549.86614.73.
PubMed Web of Science ®Google Scholar
Bry, K., and M. Hallman. 1991. Perinatal Development of inositol synthesis and catabolism in rabbit kidney. Neonatology 60 (3-4):249–257. doi: 10.1159/000243416.
Google Scholar
Burgess, J. W., J. Boucher, T. A. Neville, P. Rouillard, C. Stamler, S. Zachariah, and D. L. Sparks. 2003. Phosphatidylinositol promotes cholesterol transport and excretion. Journal of Lipid Research 44 (7):1355–63. doi: 10.1194/jlr.M300062-JLR200.
PubMed Web of Science ®Google Scholar
Burton, G. J., and E. Jauniaux. 2004. Placental oxidative stress: From miscarriage to preeclampsia. Journal of the Society for Gynecologic Investigation 11 (6):342–52. doi: 10.1016/j.jsgi.2004.03.003.
PubMedGoogle Scholar
Burton, G. J., M. Scioscia, and T. W. Rademacher. 2011. Endometrial secretions: Creating a stimulatory microenvironment within the human early placenta and implications for the aetiopathogenesis of preeclampsia. Journal of Reproductive Immunology 89 (2):118–25. doi: 10.1016/j.jri.2011.02.005.
PubMed Web of Science ®Google Scholar
Burton, L. E., and W. W. Wells. 1976. Myo-inositol metabolism during lactation and development in the rat. The prevention of lactation-induced fatty liver by dietary myo-inositol. The Journal of Nutrition 106 (11):1617–28. doi: 10.1093/jn/106.11.1617.
PubMed Web of Science ®Google Scholar
Burton, L. E., and W. W. Wells. 1977. Characterization of the lactation-dependent fatty liver in myo-inositol deficient rats. The Journal of Nutrition 107 (10):1871–83. doi: 10.1093/jn/107.10.1871.
PubMed Web of Science ®Google Scholar
Burton, L. E., and W. W. Wells. 1979. Myo-inositol deficiency: Studies on the mechanism of lactation-dependent fatty liver formation in the rat. The Journal of Nutrition 109 (8):1483–91. doi: 10.1093/jn/109.8.1483.
PubMed Web of Science ®Google Scholar
Van Calker, D, and R. H. Belmaker. 2000. The high affinity inositol transport system-implications for the pathophysiology and treatment of bipolar disorder. Bipolar Disorders 2 (2):102–7. doi:10.1034/j.1399-5618.2000.020203.x. PMC: 11252649
PubMed Web of Science ®Google Scholar
Calker, D., and R. H. Belmaker. 2000. The high affinity inositol transport system–implications for the pathophysiology and treatment of bipolar disorder. Bipolar Disorders 2 (2):102–7. doi: 10.1034/j.1399-5618.2000.020203.x.
PubMed Web of Science ®Google Scholar
Calogero, A., G. Gullo, S. La Vignera, R. Condorelli, and A. Vaiarelli. 2015. Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: A prospective double‐blind randomized placebo‐controlled study. Andrology 3 (3):491–5. doi: 10.1111/andr.12025.
PubMed Web of Science ®Google Scholar
Campbell, W. W., M. D. Haub, J. D. Fluckey, R. E. Ostlund, Jr J. P. Thyfault, H. Morse-Carrithers, M. W. Hulver, and Z. K. Birge. 2004. Pinitol supplementation does not affect insulin-mediated glucose metabolism and muscle insulin receptor content and phosphorylation in older humans. The Journal of Nutrition 134 (11):2998–3003. doi: 10.1093/jn/134.11.2998.
PubMed Web of Science ®Google Scholar
Campling, J., and D. Nixon. 1954. The inositol content of foetal blood and foetal fluids. The Journal of Physiology 126 (1):71–80. doi: 10.1113/jphysiol.1954.sp005192.
PubMed Web of Science ®Google Scholar
Carlomagno, G., and V. Unfer. 2011. Inositol safety: Clinical evidences. European Review for Medical and Pharmacological Sciences 15 (8):931–6.
PubMed Web of Science ®Google Scholar
Carlomagno, G., V. Unfer, and S. Roseff. 2011. The D-chiro-inositol paradox in the ovary. Fertility and Sterility 95 (8):2515–2516. doi: 10.1016/j.fertnstert.2011.05.027.
PubMed Web of Science ®Google Scholar
Caro, H. N., S. Kunjara, T. Rademacher, Y. Leon, D. Jones, M. Avila, and I. Varela-Nieto. 1997. Isolation and partial characterisation of insulin-mimetic inositol phosphoglycans from human liver. Biochemical and Molecular Medicine 61 (2):214–28. doi: 10.1006/bmme.1997.2607.
PubMedGoogle Scholar
Catalano, P. M., J. P. Kirwan, S. Haugel-de Mouzon, and J. King. 2003. Gestational diabetes and insulin resistance: Role in short-and long-term implications for mother and fetus. The Journal of Nutrition 133 (5 Suppl 2):1674S–1683S. doi: 10.1093/jn/133.5.1674S.
PubMed Web of Science ®Google Scholar
Cavalli, P., G. Tonni, E. Grosso, and C. Poggiani. 2011. Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy. Birth Defects Research Part A: Clinical and Molecular Teratology 91 (11):962–965. doi: 10.1002/bdra.22853.
PubMed Web of Science ®Google Scholar
Celentano, C.,. B. Matarrelli, G. Pavone, E. Vitacolonna, P. A. Mattei, V. Berghella, and M. Liberati. 2020. The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: A randomized controlled trial. The Journal of Maternal-Fetal & Neonatal Medicine 33 (5):743–751. doi: 10.1080/14767058.2018.1500545.
PubMedGoogle Scholar
Ceriello, A., D. Giugliano, A. Quatraro, and F. D'Onofrio. 1988. Does a common mechanism induce diverse complications of diabetes? Diabetes Care 11 (4):372–3. doi: 10.2337/diacare.11.4.372.
PubMed Web of Science ®Google Scholar
Challier, J., S. Hauguel, and V. Desmaizieres. 1986. Effect of insulin on glucose uptake and metabolism in the human placenta. The Journal of Clinical Endocrinology and Metabolism 62 (5):803–807. doi: 10.1210/jcem-62-5-803.
PubMed Web of Science ®Google Scholar
Charalampous, F. C. 1959. Biochemical studies on inositol. Journal of Biological Chemistry 234 (2):220–7.
Google Scholar
Cheang, K. I., J. P. Baillargeon, P. A. Essah, R. E. Ostlund, T. Apridonize, L. Islam, and J. E. Nestler. 2008. Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome . Metabolism: clinical and Experimental 57 (10):1390–7. doi: 10.1016/j.metabol.2008.05.008.
PubMed Web of Science ®Google Scholar
Cheng, M.-H., and P.-H. Wang. 2009. Placentation abnormalities in the pathophysiology of preeclampsia. Expert Review of Molecular Diagnostics 9 (1):37–49. doi: 10.1586/14737159.9.1.37.
PubMed Web of Science ®Google Scholar
Chiu, T. T., M. S. Rogers, E. L. Law, C. M. Briton-Jones, L. Cheung, and C. J. Haines. 2002. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: Relationship with oocyte quality. Human Reproduction 17 (6):1591–6. doi: 10.1093/humrep/17.6.1591.
PubMed Web of Science ®Google Scholar
Chu, A. H., Tint, M. T. Chang, H. F. Wong, G. Yuan, W. L. Tull, D. Nijagal, B. Narayana, V. K. Meikle, and P. J. Chang Kt. 2020. High placental inositol content associated with suppressed pro-adipogenic effects of maternal glycaemia in offspring: The GUSTO cohort. International Journal of Obesity 1–11.
Web of Science ®Google Scholar
Chu, S. H. W., and D. Hegsted. 1980. Myo-inositol deficiency in gerbils: Comparative study of the intestinal lipodystrophy in Meriones unguiculatus and Meriones libycus. The Journal of Nutrition 110 (6):1209–16. doi: 10.1093/jn/110.6.1209.
PubMed Web of Science ®Google Scholar
Chukwuma, C. I., M. A. Ibrahim, and M. S. Islam. 2016. Myo-inositol inhibits intestinal glucose absorption and promotes muscle glucose uptake: A dual approach study. Journal of Physiology and Biochemistry 72 (4):791–801. doi: 10.1007/s13105-016-0517-1.
PubMed Web of Science ®Google Scholar
Cianci, A., M. Panella, M. Fichera, C. Falduzzi, M. Bartolo, and S. Caruso. 2015. D-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS. Gynecological Endocrinology 31 (6):483–6. doi: 10.3109/09513590.2015.1014784.
PubMed Web of Science ®Google Scholar
Clements Jr, R. 1979. The metabolism of myo-inositol by the human kidney. Journal of Laboratory and Clinical Medicine 93:210–9.
PubMed Web of Science ®Google Scholar
Cline, G. W., K. F. Petersen, M. Krssak, J. Shen, R. S. Hundal, Z. Trajanoski, S. Inzucchi, A. Dresner, D. L. Rothman, and G. I. Shulman. 1999. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. The New England Journal of Medicine 341 (4):240–6. doi: 10.1056/NEJM199907223410404.
PubMed Web of Science ®Google Scholar
Cogram, P., S. Tesh, J. Tesh, A. Wade, G. Allan, N. D. Greene, and A. J. Copp. 2002. D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects. Human Reproduction (Oxford, England) 17 (9):2451–2458. doi: 10.1093/humrep/17.9.2451.
PubMed Web of Science ®Google Scholar
Colazingari, S., M. Treglia, R. Najjar, and A. Bevilacqua. 2013. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: Results from a randomized controlled trial. Archives of Gynecology and Obstetrics 288 (6):1405–11. doi: 10.1007/s00404-013-2855-3.
PubMed Web of Science ®Google Scholar
Colone, M., G. Marelli, V. Unfer, G. Bozzuto, A. Molinari, and A. Stringaro. 2010. Inositol activity in oligoasthenoteratospermia–an in vitro study. European Review for Medical and Pharmacological Sciences 14 (10):891–6.
PubMed Web of Science ®Google Scholar
Condorelli, R. A., S. La Vignera, L. M. Mongioì, S. G. Vitale, A. S. Laganà, L. Cimino, and A. E. Calogero. 2017. A. Myo-inositol as a male fertility molecule: Speed them up. European Review for Medical and Pharmacological Sciences 21 (2 Suppl):30–35.
PubMedGoogle Scholar
Copp, A. J., and N. D. Greene. 2010. Genetics and development of neural tube defects. The Journal of Pathology 220 (2):217–230. doi: 10.1002/path.2643.
PubMed Web of Science ®Google Scholar
Coppey, L. J., J. S. Gellett, E. P. Davidson, J. A. Dunlap, and M. A. Yorek. 2002. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. International Journal of Experimental Diabetes Research 3 (1):21–36. doi: 10.1080/15604280212525.
PubMedGoogle Scholar
Corrado, F., R. D’Anna, G. Di Vieste, D. Giordano, B. Pintaudi, A. Santamaria, and A. Di Benedetto. 2011. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine 28 (8):972–975. doi: 10.1111/j.1464-5491.2011.03284.x.
PubMed Web of Science ®Google Scholar
Coupland, N. J., C. J. Ogilvie, K. M. Hegadoren, P. Seres, C. C. Hanstock, and P. S. Allen. 2005. Decreased prefrontal Myo-inositol in major depressive disorder. Biological Psychiatry 57 (12):1526–34. doi: 10.1016/j.biopsych.2005.02.027.
PubMed Web of Science ®Google Scholar
Coustan, D. R. 2013. Can a dietary supplement prevent gestational diabetes mellitus? Diabetes Care 36 (4):777–9. doi: 10.2337/dc12-2505.
PubMed Web of Science ®Google Scholar
Crawford, M. 2000. Placental delivery of arachidonic and docosahexaenoic acids: implications for the lipid nutrition of preterm infants. The American Journal of Clinical Nutrition 71 (1 Suppl):275S–284S. doi: 10.1093/ajcn/71.1.275S.
PubMed Web of Science ®Google Scholar
Crawford, T. J., C. A. Crowther, J. Alsweiler, and J. Brown. 2015. Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes. Cochrane Database of Systematic Reviews
Google Scholar
Crowther, C. A., J. E. Hiller, J. R. Moss, A. J. McPhee, W. S. Jeffries, and J. S. Robinson. 2005. Australian carbohydrate intolerance study in pregnant women trial G. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine 352 (24):2477–2486. doi: 10.1056/NEJMoa042973.
PubMed Web of Science ®Google Scholar
Croze, M. L., A. Géloën, and C. O. Soulage. 2015. Abnormalities in myo-inositol metabolism associated with type 2 diabetes in mice fed a high-fat diet: Benefits of a dietary myo-inositol supplementation. British Journal of Nutrition 113 (12):1862–75. doi: 10.1017/S000711451500121X.
PubMed Web of Science ®Google Scholar
Croze, M. L., and C. O. Soulage. 2013. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 95 (10):1811–27. doi: 10.1016/j.biochi.2013.05.011.
PubMed Web of Science ®Google Scholar
Czech, M. P. 2000. PIP2 and PIP3: Complex roles at the cell surface. Cell 100 (6):603–6. doi: 10.1016/S0092-8674(00)80696-0.
PubMed Web of Science ®Google Scholar
D’Anna, R., and A. Santamaria. 2018. Myo-inositol supplementation in gestational diabetes. Nutrition and diet in maternal diabetes, 229–35.Springer.
Google Scholar
D’anna, R., V. Di Benedetto, P. Rizzo, E. Raffone, M. Interdonato, F. Corrado, and A. Di Benedetto. 2012. Myo-inositol may prevent gestational diabetes in PCOS women. Gynecological Endocrinology 28 (6):440–2. doi: 10.3109/09513590.2011.633665.
PubMed Web of Science ®Google Scholar
D’Oria, R., L. Laviola, M. Scioscia, F. Fascilla, S. Bettocchi, and F. Giorgino. 2017. PKB/Akt phosphorylation in human umbilical vein endothelial cells is highly induced by myo-inositol and D-chiro inositol: Novel potential insights in the pathogenesis of preeclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 7:56. doi: 10.1016/j.preghy.2016.10.005.
Google Scholar
DʼAnna, R., A. Di Benedetto, A. Scilipoti, A. Santamaria, M. L. Interdonato, E. Petrella, I. Neri, B. Pintaudi, F. Corrado, and F. Facchinetti. 2015. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: A randomized controlled trial. Obstetrics and Gynecology 126 (2):310–315. doi: 10.1097/AOG.0000000000000958.
PubMed Web of Science ®Google Scholar
D'Anna, R., A. Scilipoti, D. Giordano, C. Caruso, M. L. Cannata, M. L. Interdonato, F. Corrado, and A. Di Benedetto. 2013. Di Benedetto A. myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: A prospective, randomized, placebo-controlled study. Diabetes Care 36 (4):854–857. doi: 10.2337/dc12-1371.
PubMed Web of Science ®Google Scholar
Daughaday, W. H., and J. Larner. 1954. The renal excretion of inositol in normal and diabetic human beings. The Journal of Clinical Investigation 33 (3):326–32. doi: 10.1172/JCI102901.
PubMed Web of Science ®Google Scholar
Davanzo, P., K. Yue, M. A. Thomas, T. Belin, J. Mintz, T. Venkatraman, E. Santoro, S. Barnett, and J. McCracken. 2003. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. The American Journal of Psychiatry 160 (8):1442–52. doi: 10.1176/appi.ajp.160.8.1442.
PubMed Web of Science ®Google Scholar
Davanzo, P., M. A. Thomas, K. Yue, T. Oshiro, T. Belin, M. Strober, and J. McCracken. 2001. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 24 (4):359–69. doi: 10.1016/S0893-133X(00)00207-4.
PubMed Web of Science ®Google Scholar
Davis, A., M. Christiansen, J. F. Horowitz, S. Klein, M. K. Hellerstein, and R. E. Ostlund. 2000. Effect of pinitol treatment on insulin action in subjects with insulin resistance. Diabetes Care 23 (7):1000–5. doi: 10.2337/diacare.23.7.1000.
PubMed Web of Science ®Google Scholar
Dawonauth, L., L. Rademacher, A. D. L’Omelette, S. Jankee, M. Y. L. K. Yan, R. B. Jeeawoody, and T. W. Rademacher. 2014. Urinary inositol phosphoglycan-P type: Near patient test to detect preeclampsia prior to clinical onset of the disease. A study on 416 pregnant Mauritian women. Journal of Reproductive Immunology 101-102:148–152. doi: 10.1016/j.jri.2013.06.001.
PubMed Web of Science ®Google Scholar
De, V. L., A. M. La, V. Cappelli, A. Stendardi, R. Focarelli, M. Musacchio, and P. Piomboni. 2012. Evaluation of the treatment with D-chiro-inositol on levels of oxidative stress in PCOS patients. Minerva Ginecologica 64:531–8.
PubMedGoogle Scholar
Debierre-Grockiego, F., and R. T. Schwarz. 2010. Immunological reactions in response to apicomplexan glycosylphosphatidylinositolsF Debierre-Grockiego and R T Schwarz. Glycobiology 20 (7):801–11. doi: 10.1093/glycob/cwq038.
PubMed Web of Science ®Google Scholar
Deborde, S., J. Schofield, and T. Rademacher. 2003. Placental GPI-PLD is of maternal origin and its GPI substrate is absent from placentae of pregnancies associated with pre-eclampsia. Journal of Reproductive Immunology 59 (2):277–294. doi: 10.1016/S0165-0378(03)00054-8.
PubMed Web of Science ®Google Scholar
Del Monte, M. A., R. Rabbani, T. C. Diaz, S. A. Lattimer, J. Nakamura, M. C. Brennan, and D. A. Greene. 1991. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose: In vitro model of myo-inositol depletion hypothesis of diabetic complications. Diabetes 40 (10):1335–45. doi: 10.2337/diabetes.40.10.1335.
PubMed Web of Science ®Google Scholar
Delhaes, F., S. A. Giza, T. Koreman, G. Eastabrook, C. A. McKenzie, S. Bedell, T. R. H. Regnault, and B. de Vrijer. 2018. Altered maternal and placental lipid metabolism and fetal fat development in obesity: Current knowledge and advances in non-invasive assessment. Placenta 69:118–124. doi: 10.1016/j.placenta.2018.05.011.
PubMed Web of Science ®Google Scholar
Desoye, G., and S. Hauguel-de Mouzon. 2007. The human placenta in gestational diabetes mellitus: The insulin and cytokine network. Diabetes Care 30 (Supplement 2):S120–S126. doi: 10.2337/dc07-s203.
PubMedGoogle Scholar
Dessì, A., and V. Fanos. 2013. Myoinositol: A new marker of intrauterine growth restriction? Journal of Obstetrics and Gynaecology: Gynaecology 33 (8):776–80. doi: 10.3109/01443615.2013.831046.
PubMedGoogle Scholar
Di Cianni, G., R. Miccoli, L. Volpe, C. Lencioni, and S. Del Prato. 2003. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes/Metabolism Research and Reviews 19 (4):259–270. doi: 10.1002/dmrr.390.
PubMed Web of Science ®Google Scholar
Di Daniel, E., M. H. Mok, E. Mead, C. Mutinelli, E. Zambello, L. L. Caberlotto, T. J. Pell, C. J. Langmead, A. J. Shah, G. Duddy, et al. 2009. Evaluation of expression and function of the H+/myo-inositol transporter HMIT. BMC Cell Biology 10 (1):54. doi: 10.1186/1471-2121-10-54.
PubMedGoogle Scholar
Di Paolo, G., and P. De Camilli. 2006. Phosphoinositides in cell regulation and membrane dynamics. Nature 443 (7112):651–7. doi: 10.1038/nature05185.
PubMed Web of Science ®Google Scholar
Dona, G., C. Sabbadin, C. Fiore, M. Bragadin, F. L. Giorgino, E. Ragazzi, C. G. Bordin, and L. Armanini. 2012. D. Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome. European Journal of Endocrinology 166:703–10.
PubMed Web of Science ®Google Scholar
D'Oria, R., L. Laviola, F. Giorgino, V. Unfer, S. Bettocchi, and M. Scioscia. 2017. PKB/Akt and MAPK/ERK phosphorylation is highly induced by inositols: Novel potential insights in endothelial dysfunction in preeclampsia. Pregnancy Hypertension 10:107–112. doi: 10.1016/j.preghy.2017.07.001.
PubMed Web of Science ®Google Scholar
D'Souza, K., and R. M. Epand. 2014. Enrichment of phosphatidylinositols with specific acyl chains. Biochimica et Biophysica Acta (BBA) - Biomembranes 1838 (6):1501–8. doi: 10.1016/j.bbamem.2013.10.003.
PubMed Web of Science ®Google Scholar
Ehrmann, D. A. 2005. Polycystic ovary syndrome. The New England Journal of Medicine 352 (12):1223–36. doi: 10.1056/NEJMra041536.
PubMed Web of Science ®Google Scholar
Ehrmann, D. A., R. B. Barnes, R. L. Rosenfield, M. K. Cavaghan, and J. Imperial. 1999. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22 (1):141–6. doi: 10.2337/diacare.22.1.141.
PubMed Web of Science ®Google Scholar
Einat, H., and R. Belmaker. 2001. The effects of inositol treatment in animal models of psychiatric disorders. Journal of Affective Disorders 62 (1-2):113–121. doi: 10.1016/S0165-0327(00)00355-4.
PubMed Web of Science ®Google Scholar
Eisenberg, F., Jr, and A. H. Bolden. 1963. Biosynthesis of inositol in rat testis homogenate. Biochemical and Biophysical Research Communications 12 (1):72–77. doi: 10.1016/0006-291X(63)90416-9.
Web of Science ®Google Scholar
Elased, K. M., K. Gumaa, J. De Souza, H. Rahmoune, J. H. Playfair, and T. Rademacher. 2001. Reversal of type 2 diabetes in mice by products of malaria parasites: II. Role of inositol phosphoglycans (IPGs). Molecular Genetics and Metabolism 73 (3):248–58. doi: 10.1006/mgme.2001.3186.
PubMed Web of Science ®Google Scholar
Eriksson, U. J., and L. H. Borg. 1993. Diabetes and embryonic malformations: Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42 (3):411–9. doi: 10.2337/diab.42.3.411.
PubMed Web of Science ®Google Scholar
Eriksson, U., and L. Borg. 1991. Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34 (5):325–31. doi: 10.1007/BF00405004.
PubMed Web of Science ®Google Scholar
Facchinetti, F., M. Bizzarri, S. Benvenga, R. D’Anna, A. Lanzone, C. Soulage, D. G. C. Renzo, M. Hod, P. Cavalli, and T. T. Chiu. 2015. Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: The link between metabolic syndrome and PCOS. European Journal of Obstetrics & Gynecology and Reproductive Biology 195:72–6.
PubMed Web of Science ®Google Scholar
Fagerberg, L., B. M. Hallström, P. Oksvold, C. Kampf, D. Djureinovic, J. Odeberg, M. Habuka, S. Tahmasebpoor, A. Danielsson, K. Edlund, et al. 2014. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Molecular & Cellular Proteomics: Proteomics 13 (2):397–406. doi: 10.1074/mcp.M113.035600.
PubMed Web of Science ®Google Scholar
Falavigna, M., M. I. Schmidt, J. Trujillo, L. F. Alves, E. R. Wendland, M. R. Torloni, S. Colagiuri, and B. B. Duncan. 2012. Effectiveness of gestational diabetes treatment: A systematic review with quality of evidence assessment. Diabetes Research and Clinical Practice 98 (3):396–405. doi: 10.1016/j.diabres.2012.09.002.
PubMed Web of Science ®Google Scholar
Farese, R. V. 1983. The phosphatidate-phosphoinositide cycle: An intracellular messenger system in the action of hormones and neurotransmitters. Metabolism 32 (6):628–41. doi: 10.1016/0026-0495(83)90035-5.
PubMed Web of Science ®Google Scholar
Farese, R. V., M. Standaert, K. Yamada, L. Huang, C. Zhang, D. Cooper, Z. Wang, Y. Yang, S. Suzuki, and T. Toyota. 1994. Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats. Proceedings of the National Academy of Sciences 91 (23):11040–4. doi: 10.1073/pnas.91.23.11040.
PubMed Web of Science ®Google Scholar
Farren, M., N. Daly, A. McKeating, B. Kinsley, M. J. Turner, and S. Daly. 2017. The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: A randomized controlled trial. Diabetes Care 40 (6):759–763. doi: 10.2337/dc16-2449.
PubMed Web of Science ®Google Scholar
Fenili, D. 2010. Characterization of inositol transporters as a method for drug delivery to the central nervous system.
Google Scholar
Fenili, D., M. Brown, R. Rappaport, and J. McLaurin. 2007. Properties of scyllo–inositol as a therapeutic treatment of AD-like pathology. Journal of Molecular Medicine (Berlin, Germany) 85 (6):603–11. doi: 10.1007/s00109-007-0156-7.
PubMed Web of Science ®Google Scholar
Fisher, S. K., J. E. Novak, and B. W. Agranoff. 2002. Inositol and higher inositol phosphates in neural tissues: Homeostasis, metabolism and functional significance. Journal of Neurochemistry 82 (4):736–754. doi: 10.1046/j.1471-4159.2002.01041.x.
PubMed Web of Science ®Google Scholar
Formuso, C., M. Stracquadanio, and L. Ciotta. 2015. Myo-inositol vs. D-chiro inositol in PCOS treatment. Minerva Ginecologica 67 (4):321–325.
PubMed Web of Science ®Google Scholar
Fraser, D., S. Weitzman, J. Leiberman, and E. Eschwege. 1990. Factors influencing birth weight in newborns of diabetic and non-diabetic women a population based study. European Journal of Epidemiology 6 (4):427–431. doi: 10.1007/BF00151720.
PubMed Web of Science ®Google Scholar
Fraticelli, F.,. C. Celentano, I. A. Zecca, G. Di Vieste, B. Pintaudi, M. Liberati, M. Franzago, M. Di Nicola, and E. Vitacolonna. 2018. Effect of inositol stereoisomers at different dosages in gestational diabetes: An open-label, parallel, randomized controlled trial. Acta Diabetologica 55 (8):805–812. doi: 10.1007/s00592-018-1157-4.
PubMed Web of Science ®Google Scholar
Freedman, N. D., R. Sinha, S. C. Moore, A. J. Cross, J. N. Sampson, S. Boca, N. E. Caporaso, and W.-Y. Huang. 2014. Metabolites of tobacco smoking and colorectal cancer risk. Carcinogenesis 35 (7):1516–22. doi: 10.1093/carcin/bgu071.
PubMed Web of Science ®Google Scholar
Frej, A. D., G. P. Otto, and R. S. Williams. 2017. Tipping the scales: Lessons from simple model systems on inositol imbalance in neurological disorders. European Journal of Cell Biology 96 (2):154–163. doi: 10.1016/j.ejcb.2017.01.007.
PubMed Web of Science ®Google Scholar
Frey, R., D. Metzler, P. Fischer, A. Heiden, J. Scharfetter, E. Moser, and S. Kasper. 1998. Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla. Journal of Psychiatric Research 32 (6):411–20. doi: 10.1016/S0022-3956(98)00033-8.
PubMed Web of Science ®Google Scholar
Fruen, B., and B. Lester. 1991. High-affinity [3 H] inositol uptake by dissociated brain cells and cultured fibroblasts from fetal mice. Neurochemical Research 16 (8):913–918. doi: 10.1007/BF00965541.
PubMed Web of Science ®Google Scholar
Fukami, K., and T. Takenawa. 1989. Quantitative changes in polyphosphoinositides 1, 2-diacylglycerol and inositol 1, 4, 5-trisphosphate by platelet-derived growth factor and prostaglandin F2 alpha. The Journal of Biological Chemistry 264 (25):14985–9.
PubMed Web of Science ®Google Scholar
Gaggini, M., C. Saponaro, and A. Gastaldelli. 2015. Not all fats are created equal: Adipose vs. ectopic fat, implication in cardiometabolic diseases. Hormone Molecular Biology and Clinical Investigation 22 (1):7–18. doi: 10.1515/hmbci-2015-0006.
PubMedGoogle Scholar
Galasko, G.,. S. Abe, K. Lilley, C. Zhang, and J. Larner. 1996. Circulating factors and insulin resistance. II. The action of the novel myo-inositol cyclic 1,2-inositol phosphate phosphoglycan insulin antagonist from human plasma in regulating pyruvate dehydrogenase phosphatase. The Journal of Clinical Endocrinology and Metabolism 81 (3):1051–7. doi: 10.1210/jcem.81.3.8772575.
PubMed Web of Science ®Google Scholar
Gallo, L. A., H. L. Barrett, and M. D. Nitert. 2017. Review: Placental transport and metabolism of energy substrates in maternal obesity and diabetes. Placenta 54:59–67. doi: 10.1016/j.placenta.2016.12.006.
PubMed Web of Science ®Google Scholar
Ganapathy, V., P. D. Prasad, M. E. Ganapathy, and F. H. Leibach. 2000. Placental transporters relevant to drug distribution across the maternal-fetal interface. The Journal of Pharmacology and Experimental Therapeutics 294 (2):413–420.
PubMed Web of Science ®Google Scholar
Gao J, Nalls MA, Shi M, Joubert BR, Hernandez DG, Huang X, Hollenbeck A, Singleton AB, Chen H. 2012. An exploratory analysis on gene-environment interactions for Parkinson disease. Neurobiology of Aging, 33:2528.e1.e2521–2528.e2526 doi: 10.1016/j.neurobiolaging.2012.06.007.
Google Scholar
Garcia-Perez, A., and M. B. Burg. 1990. Importance of organic osmolytes for osmoregulation by renal medullary cells. Hypertension16 (6):595–602. doi: 10.1161/01.HYP.16.6.595.
PubMed Web of Science ®Google Scholar
Gateva, A., V. Unfer, and Z. Kamenov. 2018. The use of inositol (s) isomers in the management of polycystic ovary syndrome: A comprehensive review. Gynecological Endocrinology 34 (7):545–6. doi: 10.1080/09513590.2017.1421632.
PubMed Web of Science ®Google Scholar
Gavin, G., and E. McHenry. 1941. Inositol: A lipotropic factor. Journal of Biological Chemistry 139
Google Scholar
Genazzani, A. D., A. Prati, S. Santagni, F. Ricchieri, E. Chierchia, E. Rattighieri, A. Campedelli, T. Simoncini, and P. G. Artini. 2012. Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. Gynecological Endocrinology 28 (12):969–973. doi: 10.3109/09513590.2012.685205.
PubMed Web of Science ®Google Scholar
Gerli, S., E. Papaleo, A. Ferrari, D. Renzo, and G. Randomized. 2007. Double blind placebo-controlled trial: Effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. European Review for Medical and Pharmacological Sciences 11:347–54.
PubMed Web of Science ®Google Scholar
Ghulmiyyah, L., and B. Sibai. 2012. Maternal mortality from preeclampsia/eclampsia. Seminars in Perinatology 36 (1):56–59. doi: 10.1053/j.semperi.2011.09.011.
PubMed Web of Science ®Google Scholar
Giordano, D., F. Corrado, A. Santamaria, S. Quattrone, B. Pintaudi, A. Di Benedetto, and R. D'Anna. 2011. Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: A perspective, randomized, placebo-controlled study. Menopause18 (1):102–104. doi: 10.1097/gme.0b013e3181e8e1b1.
PubMed Web of Science ®Google Scholar
Godfrey, K. M., W. Cutfield, S. Y. Chan, P. N. Baker, and Y. S. Chong. 2017. Nutritional intervention preconception and during pregnancy to maintain healthy glucose metabolism and offspring health (“NiPPeR”): Study protocol for a randomised controlled trial. Trials 18 (1):131. doi: 10.1186/s13063-017-1875-x.
PubMedGoogle Scholar
Goel, M., and V. N. Azev. 2009. The biological activity of structurally defined inositol glycans.
Google Scholar
Goodarzi, M. O., D. A. Dumesic, G. Chazenbalk, and R. Azziz. 2011. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nature Reviews. Endocrinology 7 (4):219–31. doi: 10.1038/nrendo.2010.217.
PubMed Web of Science ®Google Scholar
Grases, F., Simonet, B. M. Vucenik, I. Prieto, R. M. Costa,‐Bauzá, A. March, J. G. Shamsuddin. and A. M. 2001. Absorption and excretion of orally administered inositol hexaphosphate (IP6 or phytate) in humans. BioFactors 15 (1):53–61. doi: 10.1002/biof.5520150105.
PubMed Web of Science ®Google Scholar
Greene, D. A., P. V. De Jesus, Jr., and A. I. Winegrad. 1975. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. The Journal of Clinical Investigation 55 (6):1326–36. doi: 10.1172/JCI108052.
PubMed Web of Science ®Google Scholar
Greene, D., and A. Mackway. 1986. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition. Diabetes 35 (10):1106–8. doi: 10.2337/diab.35.10.1106.
PubMed Web of Science ®Google Scholar
Greene, D., S. Chakrabarti, S. Lattimer, and A. Sima. 1987. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol. The Journal of Clinical Investigation 79 (5):1479–85. doi: 10.1172/JCI112977.
PubMed Web of Science ®Google Scholar
Groenen, P. M., H. M. Merkus, F. C. Sweep, R. A. Wevers, F. S. Janssen, and R. P. Steegers-Theunissen. 2003. Kinetics of myo-inositol loading in women of reproductive age. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 40 (1):79–85. doi: 10.1258/000456303321016213.
PubMedGoogle Scholar
Groenen, P. M., P. G. Peer, R. A. Wevers, D. W. Swinkels, B. Franke, E. C. Mariman, and R. P. Steegers-Theunissen. 2003. myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. American Journal of Obstetrics and Gynecology 189 (6):1713–1719. doi: 10.1016/S0002-9378(03)00807-X.
PubMed Web of Science ®Google Scholar
Groenen, P. M., R. A. Wevers, F. S. Janssen, J. H. Tuerlings, J. M. Merkus, and R. P. Steegers-Theunissen. 2003. Are myo-inositol, glucose and zinc concentrations in amniotic fluid of fetuses with spina bifida different from controls? Early Human Development 71 (1):1–8. doi: 10.1016/S0378-3782(02)00040-3.
PubMed Web of Science ®Google Scholar
Guan, G.,. P. Dai, and I. Shechter. 2003. cDNA cloning and gene expression analysis of human myo-inositol 1-phosphate synthase. Archives of Biochemistry and Biophysics 417 (2):251–259. doi: 10.1016/S0003-9861(03)00388-6.
PubMed Web of Science ®Google Scholar
Guo, W., S. Shimada, H. Tajiri, A. Yamauchi, T. Yamashita, S. Okada, and M. Tohyama. 1997. Developmental regulation of Na+/myo-inositol cotransporter gene expression. Molecular Brain Research 51 (1-2):91–96. doi: 10.1016/S0169-328X(97)00220-9.
PubMedGoogle Scholar
Handwerger, S., and M. Freemark. 2000. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. Journal of Pediatric Endocrinology & Metabolism: JPEM 13 (4):343–356. doi: 10.1515/JPEM.2000.13.4.343.
PubMed Web of Science ®Google Scholar
Hansen, B., and N. Bodkin. 1986. Heterogeneity of insulin responses: Phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 29 (10):713–9. doi: 10.1007/BF00870281.
PubMed Web of Science ®Google Scholar
Hansen, S. B. 2015. Lipid agonism: The PIP 2 paradigm of ligand-gated ion channels. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1851:620–8.
PubMed Web of Science ®Google Scholar
Harwood, A. J. 2005. Lithium and bipolar mood disorder: The inositol-depletion hypothesis revisited. Molecular Psychiatry 10 (1):117–26. doi: 10.1038/sj.mp.4001618.
PubMed Web of Science ®Google Scholar
Hashimoto, M., S. Akazawa, M. Akazawa, M. Akashi, H. Yamamoto, Y. Maeda, Y. Yamaguchi, H. Yamasaki, D. Tahara, and T. Nakanishi. 1990. Effects of hyperglycaemia on sorbitol and myo-inositol contents of cultured embryos: Treatment with aldose reductase inhibitor and myo-inositol supplementation. Diabetologia 33 (10):597–602. doi: 10.1007/BF00400203.
PubMed Web of Science ®Google Scholar
Hauguel-de Mouzon, S., J. Lepercq, and P. Catalano. 2006. The known and unknown of leptin in pregnancy. American Journal of Obstetrics and Gynecology 194 (6):1537–1545. doi: 10.1016/j.ajog.2005.06.064.
PubMed Web of Science ®Google Scholar
Hauser, G., and V. N. Finelli. 1963. The biosynthesis of free and phosphatide myo-inositol from glucose by mammalian tissue slices. Journal of Biological Chemistry 238:64.
PubMed Web of Science ®Google Scholar
Häussinger, D. 1998. Osmoregulation of liver cell function: signalling, osmolytes and cell heterogeneity. Cell Volume Regulation. Vol 123, ; 185–204 Karger Publishers.
Google Scholar
Hayashi, E., R. Hasegawa, and T. Tomita. 1976. Accumulation of neutral lipids in Saccharomyces carlsbergensis by myo-inositol deficiency and its mechanism. Reciprocal regulation of yeast acetyl-CoA carboxylase by fructose bisphosphate and citrate. The Journal of Biological Chemistry 251 (18):5759–69.
PubMed Web of Science ®Google Scholar
Hayashi, E., T. Maeda, R. Hasegawa, and T. Tomita. 1978. The effect of myo-inositol deficiency on lipid metabolism in rats: III. The mechanism of an enhancement in lipolysis due to myo-inositol deficiency in rats. Biochimica et Biophysica Acta 531 (2):197–205. doi: 10.1016/0005-2760(78)90143-1.
PubMedGoogle Scholar
Hegsted, D., K. Hayes, A. Gallagher, and H. Hanford. 1973. Inositol deficiency: An intestinal lipodystrophy in the gerbil. The Journal of Nutrition 103 (2):302–7. doi: 10.1093/jn/103.2.302.
PubMed Web of Science ®Google Scholar
Heimark, D., J. McAllister, and J. Larner. 2014. Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls. Endocrine Journal 61 (2):111–7. doi: 10.1507/endocrj.EJ13-0423.
PubMed Web of Science ®Google Scholar
Hernández-Mijares, A., C. Bañuls, J. E. Peris, N. Monzó, A. Jover, L. Bellod, V. M. Victor, and M. Rocha. 2013. A single acute dose of pinitol from a naturally-occurring food ingredient decreases hyperglycaemia and circulating insulin levels in healthy subjects. Food Chemistry 141 (2):1267–72. doi: 10.1016/j.foodchem.2013.04.042.
PubMed Web of Science ®Google Scholar
Herrera, E., and H. Ortega-Senovilla. 2010. Disturbances in lipid metabolism in diabetic pregnancy–are these the cause of the problem? Best Practice & Research Clinical Endocrinology & Metabolism 24 (4):515–525. doi: 10.1016/j.beem.2010.05.006.
PubMed Web of Science ®Google Scholar
Herrera, E., and H. Ortega-Senovilla. 2018. Implications of lipids in neonatal body weight and fat mass in gestational diabetic mothers and non-diabetic controls. Current Diabetes Reports 18 (2):7. doi: 10.1007/s11892-018-0978-4.
PubMed Web of Science ®Google Scholar
Hipps, P. P., K. E. Ackermann, and W. R. Sherman. 1982. Inositol epimerase - Inosose reductase from bovine brain. Methods in enzymology. Vol 89, 593–8. Academic Press.
Google Scholar
Hipps, P. P., W. H. Holland, and W. R. Sherman. 1977. Interconversion of myo- and scyllo-inositol with simultaneous formation of neo-inositol by an NADP + dependent epimerase from bovine brain. Biochemical and Biophysical Research Communications 77 (1):340–346. doi: 10.1016/S0006-291X(77)80202-7.
PubMed Web of Science ®Google Scholar
Holub, B. J. 1986. Metabolism and function of myo-inositol and inositol phospholipids. Annual Review of Nutrition 6:563–97. doi: 10.1146/annurev.nu.06.070186.003023.
PubMed Web of Science ®Google Scholar
Holub, B. J. The nutritional significance, metabolism, and function of myo-inositol and phosphatidylinositol in health and disease. Advances in nutritional research, 1982, 107–41. Springer.
Google Scholar
Hong, J. H., H. W. Jang, Y. E. Kang, J. H. Lee, K. S. Kim, H. J. Kim, K. R. Park, and B. J. Ku. 2012. Urinary chiro-and myo-inositol levels as a biological marker for type 2 diabetes mellitus. Disease Markers 33 (4):193–199. doi: 10.1155/2012/734718.
PubMed Web of Science ®Google Scholar
Hori, H.,. T. Sasaoka, H. Ishihara, T. Wada, S. Murakami, M. Ishiki, and M. Kobayashi. 2002. Association of SH2-containing inositol phosphatase 2 with the insulin resistance of diabetic db/db mice. Diabetes 51 (8):2387–94. doi: 10.2337/diabetes.51.8.2387.
PubMed Web of Science ®Google Scholar
Hu, M. L., Y. K. Chen, and Y. F. Lin. 1995. The antioxidant and prooxidant activity of some B vitamins and vitamin-like compounds. Chemico-Biological Interactions 97 (1):63–73. doi: 10.1016/0009-2797(95)03608-8.
PubMed Web of Science ®Google Scholar
Huang, L., M. Fonteles, D. Houston, C. Zhang, and J. Larner. 1993. Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Endocrinology 132 (2):652–7. doi: 10.1210/endo.132.2.8425485.
PubMed Web of Science ®Google Scholar
I, E., H. d. Valk, B.Moll, E. t. Braak, and V. G. 2002. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia 45 (11):1484–9. doi:10.1007/s00125-002-0958-7.
PubMed Web of Science ®Google Scholar
Isaacks, R. E., A. S. Bender, C. Y. Kim, Y. F. Shi, and M. D. Norenberg. 1999. Effect of osmolality and anion channel inhibitors on myo‐inositol efflux in cultured astrocytes. Journal of Neuroscience Research 57 (6):866–871. doi: 10.1002/(SICI)1097-4547(19990915)57:6<866::AID-JNR12>3.0.CO;2-K.
PubMed Web of Science ®Google Scholar
Ishida, S., A. Funakoshi, K. Miyasaka, H. Shimokata, F. Ando, and S. Takiguchi. 2006. Association of SH-2 containing inositol 5′-phosphatase 2 gene polymorphisms and hyperglycemia. Pancreas 33:63–7. doi: 10.1097/01.mpa.0000222317.82231.16.
PubMed Web of Science ®Google Scholar
Islam, M. O., P. Selvam, R. Appukuttan Pillai, O. C. Watkins, and S. Y. Chan. 2019. An enzymatic assay for quantification of inositol in human term placental tissue. Analytical Biochemistry 586:113409. doi: 10.1016/j.ab.2019.113409.
PubMed Web of Science ®Google Scholar
Iuorno, M., Maria, J. Jakubowicz, M. Daniela, J. Baillargeon, M. Jean-Patrice, D. B. Pamela, Gunn, M. Ronald, D. Allan, P. Nestler, G, et al. 2002. Effects of D-chiro-inositol in lean women with the polycystic ovary syndrome. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 8 (6):417–23. doi: 10.4158/EP.8.6.417.
PubMedGoogle Scholar
Jackson, P. S., and K. Strange. 1993. Volume-sensitive anion channels mediate swelling-activated inositol and taurine efflux. American Journal of Physiology-Cell Physiology 265 (6):C1489–C1500. doi: 10.1152/ajpcell.1993.265.6.C1489.
Google Scholar
Jansson, N., F. J. Rosario, F. Gaccioli, S. Lager, H. N. Jones, S. Roos, T. Jansson, and T. L. Powell. 2013. Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. The Journal of Clinical Endocrinology & Metabolism 98 (1):105–113. doi: 10.1210/jc.2012-2667.
PubMed Web of Science ®Google Scholar
Jayabalan, N., S. Nair, Z. Nuzhat, G. E. Rice, F. A. Zuñiga, L. Sobrevia, A. Leiva, C. Sanhueza, J. A. Gutiérrez, M. Lappas, et al. 2017. Cross talk between adipose tissue and placenta in obese and gestational diabetes mellitus pregnancies via exosomes. Frontiers in Endocrinology 8:239. doi: 10.3389/fendo.2017.00239.
PubMed Web of Science ®Google Scholar
Jenkins, C., R. Wilson, J. Roberts, H. Miller, J. H. McKillop, and J. J. Walker. 2000. Antioxidants: Their role in pregnancy and miscarriage. Antioxidants & Redox Signaling 2 (3):623–8. doi: 10.1089/15230860050192369.
PubMed Web of Science ®Google Scholar
Jiang, W. D., L. Feng, Y. Liu, J. Jiang, and X. Q. Zhou. 2009. Myo‐inositol prevents oxidative damage, inhibits oxygen radical generation and increases antioxidant enzyme activities of juvenile Jian carp (Cyprinus carpio var. Jian. Aquaculture Research 40 (15):1770–6. doi: 10.1111/j.1365-2109.2009.02283.x.
Web of Science ®Google Scholar
Johansson, M., T. Jansson, and T. Powell. 2000. Na+-K+-ATPase is distributed to microvillous and basal membrane of the syncytiotrophoblast in human placenta. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 279 (1):R287–R294. doi: 10.1152/ajpregu.2000.279.1.R287.
PubMed Web of Science ®Google Scholar
Jung, T.-S., J.-R. Hahm, J.-J. Kim, J.-H. Jung, M.-Y. Kang, S.-W. Moon, K.-W. Lee, H.-C. Kim, J.-D. Lee, J.-H. Kim, et al. 2005. Determination of urinary myo-/chiro-inositol ratios from Korean diabetes patients. Yonsei Medical Journal 46 (4):532–8. doi: 10.3349/ymj.2005.46.4.532.
PubMed Web of Science ®Google Scholar
Kaaja, R., H. Laivuori, M. Laakso, M. J. Tikkanen, and O. Ylikorkala. 1999. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 48 (7):892–896. doi: 10.1016/S0026-0495(99)90225-1.
PubMed Web of Science ®Google Scholar
Kagawa, S., T. Sasaoka, S. Yaguchi, H. Ishihara, H. Tsuneki, S. Murakami, K. Fukui, T. Wada, S. Kobayashi, I. Kimura, et al. 2005. Impact of SRC homology 2-containing inositol 5′-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling. The Journal of Clinical Endocrinology & Metabolism 90 (5):2911–9., doi: 10.1210/jc.2004-1724.
PubMed Web of Science ®Google Scholar
Kalra, B., S. Kalra, and J. Sharma. 2016. The inositols and polycystic ovary syndrome. Indian Journal of Endocrinology and Metabolism 20 (5):720–724. doi: 10.4103/2230-8210.189231.
PubMedGoogle Scholar
Kang, M.J., J.I. Kim, S.Y. Yoon, J. C. Kim, and I.J. Cha. 2006. Pinitol from soybeans reduces postprandial blood glucose in patients with type 2 diabetes mellitus. Journal of Medicinal Food 9 (2):182–6. doi: 10.1089/jmf.2006.9.182.
PubMed Web of Science ®Google Scholar
Kawa, J. M., R. Przybylski, and C. G. Taylor. 2003. Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat. Experimental Biology and Medicine (Maywood, N.J.) 228 (8):907–14. doi: 10.1177/153537020322800806.
PubMed Web of Science ®Google Scholar
Kennington, A. S., C. R. Hill, J. Craig, C. Bogardus, I. Raz, H. K. Ortmeyer, B. C. Hansen, G. Romero, and J. Larner. 1990. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. New England Journal of Medicine 323 (6):373–8. doi: 10.1056/NEJM199008093230603.
PubMed Web of Science ®Google Scholar
Kennington, O. A. 1992. Insulin mediators and their inositol components.
Google Scholar
Kim, H. J., K. S. Park, S. K. Lee, K. W. Min, K. A. Han, Y. K. Kim, and B. J. Ku. 2012. Effects of pinitol on glycemic control, insulin resistance and adipocytokine levels in patients with type 2 diabetes mellitus. Annals of Nutrition and Metabolism 60 (1):1–5. doi: 10.1159/000334834.
PubMed Web of Science ®Google Scholar
Kim, J. N., S. N. Han, and H. K. Kim. 2014. Phytic acid and myo-inositol support adipocyte differentiation and improve insulin sensitivity in 3T3-L1 cells. Nutrition Research 34 (8):723–31. doi: 10.1016/j.nutres.2014.07.015.
PubMed Web of Science ®Google Scholar
Kim, J., E. Darè, S. S. Rajasekaran, S. H. Ryu, P.-O. Berggren, and C. J. Barker. 2019. Inositol pyrophosphates and Akt/PKB: Is the pancreatic β-cell the exception to the rule? Cellular Signalling 58:131–6. doi: 10.1016/j.cellsig.2019.02.003.
PubMed Web of Science ®Google Scholar
Kim, J.-I., J. Kim, M.-J. Kang, M.-S. Lee, J.-J. Kim, and I.-J. Cha. 2005. Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: A randomized controlled study. European Journal of Clinical Nutrition 59 (3):456–458. doi: 10.1038/sj.ejcn.1602081.
PubMed Web of Science ®Google Scholar
Kim, M. J., K. H. Yoo, J. H. Kim, Y. T. Seo, B. W. Ha, J. H. Kho, Y. G. Shin, and C. H. Chung. 2007. Effect of pinitol on glucose metabolism and adipocytokines in uncontrolled type 2 diabetes. Diabetes Research and Clinical Practice 77 (3):S247–S251. doi: 10.1016/j.diabres.2007.01.066.
PubMedGoogle Scholar
Kondoh, G., H. Tojo, Y. Nakatani, N. Komazawa, C. Murata, K. Yamagata, Y. Maeda, T. Kinoshita, M. Okabe, R. Taguchi, et al. 2005. Angiotensin-converting enzyme is a GPI-anchored protein releasing factor crucial for fertilization. Nature Medicine 11 (2):160–6. doi: 10.1038/nm1179.
PubMed Web of Science ®Google Scholar
Krystal, G. 2000. Lipid phosphatases in the immune system. Seminars in Immunology 12 (4):397–403. doi: 10.1006/smim.2000.0222.
PubMed Web of Science ®Google Scholar
Kunjara, S., A. L. Greenbaum, D.-Y. Wang, H. N. Caro, P. McLean, C. W. Redman, and T. W. Rademacher. 2000. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: Evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Molecular Genetics and Metabolism 69 (2):144–58. doi: 10.1006/mgme.2000.2964.
PubMed Web of Science ®Google Scholar
Kunjara, S., D. Y. Wang, A. L. Greenbaum, P. McLean, A. Kurtz, and T. W. Rademacher. 1999. Inositol phosphoglycans in diabetes and obesity: Urinary levels of IPG A-type and IPG P-type, and relationship to pathophysiological changes. Molecular Genetics and Metabolism 68 (4):488–502. doi: 10.1006/mgme.1999.2936.
PubMed Web of Science ®Google Scholar
Kunjara, S., D. Y. Wang, P. McLean, A. L. Greenbaum, and T. W. Rademacher. 2000. Inositol phosphoglycans and the regulation of the secretion of leptin: In vitro effects on leptin release from adipocytes and the relationship to obesity. Molecular Genetics and Metabolism 70 (1):61–68. doi: 10.1006/mgme.2000.2988.
PubMed Web of Science ®Google Scholar
Laganà, A. S., L. Barbaro, and A. Pizzo. 2015. Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol. Archives of Gynecology and Obstetrics 291 (5):1181–6. doi: 10.1007/s00404-014-3552-6.
PubMed Web of Science ®Google Scholar
Lager, S., and T. L. Powell. 2012. Regulation of nutrient transport across the placenta. Journal of Pregnancy 2012:1–14. doi: 10.1155/2012/179827.
Google Scholar
Lamar, M., C. M. L. Foy, F. Beacher, E. Daly, M. Poppe, N. Archer, V. Prasher, K. C. Murphy, R. G. Morris, A. Simmons, et al. 2011. Down syndrome with and without dementia: An in vivo proton magnetic resonance spectroscopy study with implications for Alzheimer's disease. Neuroimage 57 (1):63–8. doi: 10.1016/j.neuroimage.2011.03.073.
PubMed Web of Science ®Google Scholar
Lampe, D., and B. V. L. Potter. 1993. Synthesis of 2-fluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate and scyllo-inositol 1,2,4-trisphosphate, novel analogues of the second messenger myo-inositol 1,4,5-trisphosphate. Tetrahedron Letters 34 (14):2365–8. doi: 10.1016/S0040-4039(00)77615-5.
Web of Science ®Google Scholar
Larner, J. 2002. D-chiro-inositol–its functional role in insulin action and its deficit in insulin resistance. Journal of Diabetes Research 3:47–60.
Google Scholar
Larner, J., D. L. Brautigan, and M. O. Thorner. 2010. D-chiro-inositol glycans in insulin signaling and insulin resistance. Molecular Medicine 16 (11-12):543–52. doi: 10.2119/molmed.2010.00107.
PubMed Web of Science ®Google Scholar
Larner, J., J. D. Price, D. Heimark, L. Smith, G. Rule, T. Piccariello, M. C. Fonteles, C. Pontes, D. Vale, and L. Huang. 2003. Isolation, structure, synthesis, and bioactivity of a novel putative insulin mediator. A galactosamine chiro-inositol pseudo-disaccharide Mn2+ chelate with insulin-like activity. Journal of Medicinal Chemistry 46 (15):3283–91. doi: 10.1021/jm030071j.
PubMed Web of Science ®Google Scholar
Larqué, E., A. Pagán, M. T. Prieto, J. E. Blanco, A. Gil-Sánchez, M. Zornoza-Moreno, M. Ruiz-Palacios, A. Gázquez, H. Demmelmair, J. J. Parrilla, et al. 2014. Placental fatty acid transfer: A key factor in fetal growth. Annals of Nutrition & Metabolism 64 (3-4):247–253., doi: 10.1159/000365028.
PubMed Web of Science ®Google Scholar
Lawrence, J., J. Guinovart, and J. Larner. 1977. Activation of rat adipocyte glycogen synthase by insulins. The Journal of Biological Chemistry 252 (2):444–50.
PubMed Web of Science ®Google Scholar
Lazar, D. F., J. J. Knez, M. E. Medof, P. Cuatrecasas, and A. R. Saltiel. 1994. Stimulation of glycogen synthesis by insulin in human erythroleukemia cells requires the synthesis of glycosyl-phosphatidylinositol. Proceedings of the National Academy of Sciences 91 (21):9665–9. doi: 10.1073/pnas.91.21.9665.
PubMed Web of Science ®Google Scholar
Lee, G., M. Price, C. Mejia, H. Galan, and J. Arroyo. 2014. Increased trophoblast expression of NFAT5/TonEBP in pre-eclamptic placentas and hyperosmolar-treated BeWo cells. European Journal of Obstetrics & Gynecology and Reproductive Biology 183:37–43. doi: 10.1016/j.ejogrb.2014.10.002.
PubMed Web of Science ®Google Scholar
Letcher, A. J., M. J. Schell, and R. F. Irvine. 2008. Do mammals make all their own inositol hexakisphosphate? Biochemical Journal 416 (2):263–70. doi: 10.1042/BJ20081417.
PubMedGoogle Scholar
Lewin, L. M., Y. Yannai, S. Melmed, and M. Weiss. 1982. myo-inositol in the reproductive tract of the female rat. The International Journal of Biochemistry 14 (2):147–150. doi: 10.1016/0020-711X(82)90154-9.
PubMedGoogle Scholar
Lewis, R. M., C. Wadsack, and G. Desoye. 2018. Placental fatty acid transfer. Current Opinion in Clinical Nutrition and Metabolic Care 21 (2):78–82. doi: 10.1097/MCO.0000000000000443.
PubMed Web of Science ®Google Scholar
Li, H.-Y., S.-P. Chang, C.-C. Yuan, H.-T. Chao, H.-T. Ng, and Y.-J. Sung. 2003. Induction of p38 mitogen-activated protein kinase-mediated apoptosis is involved in outgrowth of trophoblast cells on endometrial epithelial cells in a model of human trophoblast-endometrial interactions. Biology of Reproduction 69 (5):1515–1524. doi: 10.1095/biolreprod.103.015669.
PubMed Web of Science ®Google Scholar
Lin, X., L. Ma, C. Gopalan, and R. E. Ostlund. 2009. D-chiro-Inositol is absorbed but not synthesised in rodents. British Journal of Nutrition 102 (10):1426–1434. doi: 10.1017/S0007114509990456.
PubMed Web of Science ®Google Scholar
Lin, X., L. Ma, R. L. Fitzgerald, and R. E. Ostlund. 2009. Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells. Archives of Biochemistry and Biophysics 481 (2):197–201. doi: 10.1016/j.abb.2008.11.008.
PubMed Web of Science ®Google Scholar
Liscovitch, M., M. Czarny, G. Fiucci, and T. Xiaoqing. 2000. Phospholipase D: Molecular and cell biology of a novel gene family. Biochemical Journal 345 (3):401–415. doi: 10.1042/bj3450401.
PubMedGoogle Scholar
Lizcano, J. M., and D. R. Alessi. 2002. The insulin signalling pathway. Current Biology: CB 12 (7):R236–R238. doi: 10.1016/S0960-9822(02)00777-7.
PubMed Web of Science ®Google Scholar
Low, M. G. 2000. Structure and function of GPI-specific phospholipases. In PNH and the GPI-Linked Proteins, eds. N. S. Young and J. Moss, 239–68. San Diego: Academic Press.
Google Scholar
Loy, A., K. G. Lurie, A. Ghosh, J. M. Wilson, L. C. MacGregor, and F. M. Matschinsky. 1990. Diabetes and the myo-inositol paradox. Diabetes 39 (10):1305–12. doi: 10.2337/diab.39.10.1305.
PubMed Web of Science ®Google Scholar
Lubin, V., R. Shojai, P. Darmon, and E. Cosson. 2016. A pilot study of gestational diabetes mellitus not controlled by diet alone: First-line medical treatment with myoinositol may limit the need for insulin. Diabetes & Metabolism 42 (3):192–195. doi: 10.1016/j.diabet.2016.01.005.
PubMed Web of Science ®Google Scholar
Lubrich, B., and D. van Calker. 1999. Inhibition of the high affinity Myo-inositol transport system: A common mechanism of action of antibipolar drugs? Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 21 (4):519–29. doi: 10.1016/S0893-133X(99)00037-8.
PubMed Web of Science ®Google Scholar
Ma, K., L. A. M. Thomason, and J. McLaurin. 2012. scyllo-Inositol, Preclinical, and Clinical Data for Alzheimer’s Disease. In: Michaelis EK, Michaelis ML, eds. Advances in Pharmacology. Vol 64: Academic Press; 177–212.
Google Scholar
Ma, K., L. A. Thomason, and J. McLaurin. 2012. Scyllo-inositol, preclinical, and clinical data for Alzheimer’s disease. Advances in pharmacology. Vol 64, 177–212. Elsevier.
Google Scholar
Ma, R. C., G. E. Tutino, K. A. Lillycrop, M. A. Hanson, and W. H. Tam. 2015. Maternal diabetes, gestational diabetes and the role of epigenetics in their long term effects on offspring. Progress in Biophysics and Molecular Biology 118 (1-2):55–68. doi: 10.1016/j.pbiomolbio.2015.02.010.
PubMed Web of Science ®Google Scholar
Mackenzie, R. W., and B. T. Elliott. 2014. Akt/PKB activation and insulin signaling: A novel insulin signaling pathway in the treatment of type 2 diabetes. Diabetes, metabolic syndrome and obesity. Targets and Therapy 7:55.
Google Scholar
Magnusson-Olsson, A. L., B. Hamark, A. Ericsson, M. Wennergren, T. Jansson, and T. L. Powell. 2006. Gestational and hormonal regulation of human placental lipoprotein lipase. Journal of Lipid Research 47 (11):2551–2561. doi: 10.1194/jlr.M600098-JLR200.
PubMed Web of Science ®Google Scholar
Malik, A., F. Steinbeis, M. A. Carillo, P. H. Seeberger, B. Lepenies, and D. Varón Silva. 2020. Immunological evaluation of synthetic glycosylphosphatidylinositol glycoconjugates as vaccine candidates against malaria. ACS Chemical Biology 15 (1):171–8. doi: 10.1021/acschembio.9b00739.
PubMed Web of Science ®Google Scholar
Malvasi, A., F. Casciaro, M. Minervini, I. Kosmas, O. Mynbaev, E. Pacella, V. M. Condesnitt, A. Creanza, D. Renzo, and G. Tinelli. 2014. A. Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: A preliminary investigation. European Review for Medical and Pharmacological Sciences. 18:270–274.
PubMed Web of Science ®Google Scholar
Manna, P., and S. K. Jain. 2013. PIP3 but not PIP2 increases GLUT4 surface expression and glucose metabolism mediated by AKT/PKCζ/λ phosphorylation in 3T3L1 adipocytes. Molecular and Cellular Biochemistry 381 (1-2):291–9. doi: 10.1007/s11010-013-1714-7.
PubMed Web of Science ®Google Scholar
Mariggiò, S., C. Iurisci, J. Sebastià, J. Patton-Vogt, and D. Corda. 2006. Molecular characterization of a glycerophosphoinositol transporter in mammalian cells. FEBS Letters 580 (30):6789–96. doi: 10.1016/j.febslet.2006.11.039.
PubMed Web of Science ®Google Scholar
Marincola, F. C., A. Dessi, M. G. Pattumelli, S. Corbu, C. Ossicini, S. Ciccarelli, R. Agostino, M. Mussap, and V. Fanos. 2015. 1H NMR-based urine metabolic profile of IUGR, LGA, and AGA newborns in the first week of life. Clinica Chimica Acta; International Journal of Clinical Chemistry 451:28–34. doi: 10.1016/j.cca.2015.08.008.
PubMed Web of Science ®Google Scholar
Marion, E., P. J. Kaisaki, V. Pouillon, C. Gueydan, J. C. Levy, A. Bodson, G. Krzentowski, J.-C. Daubresse, J. Mockel, J. Behrends, et al. 2002. The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 51 (7):2012–7., doi: 10.2337/diabetes.51.7.2012.
PubMed Web of Science ®Google Scholar
Matarrelli, B., E. Vitacolonna, M. D’angelo, G. Pavone, P. A. Mattei, M. Liberati, and C. Celentano. 2013. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: A randomized controlled trial. The Journal of Maternal-Fetal & Neonatal Medicine26 (10):967–972. doi: 10.3109/14767058.2013.766691.
PubMed Web of Science ®Google Scholar
Maurizi, A. R., M. Menduni, R. Del Toro, S. Kyanvash, D. Maggi, C. Guglielmi, A. L. Pantano, G. Defeudis, E. Fioriti, S. Manfrini, et al. 2017. A pilot study of d-chiro-inositol plus folic acid in overweight patients with type 1 diabetes. Acta Diabetologica 54 (4):361–5. doi: 10.1007/s00592-016-0954-x.
PubMed Web of Science ®Google Scholar
Mayer, J., and D. Tomlinson. 1983. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia 25 (5):433–8. doi: 10.1007/BF00282524.
PubMed Web of Science ®Google Scholar
McLean, P., S. Kunjara, A. L. Greenbaum, K. Gumaa, J. López-Prados, M. Martin-Lomas, and T. W. Rademacher. 2008. Reciprocal control of pyruvate dehydrogenase kinase and phosphatase by inositol phosphoglycans dynamic state set by “push-pull” system. The Journal of Biological Chemistry 283 (48):33428–36. doi: 10.1074/jbc.M801781200.
PubMed Web of Science ®Google Scholar
McPhee, F., C. Downes, and G. Lowe. 1991. Studies of inositol analogues as inhibitors of the phosphoinositide pathway, and incorporation of 2-deoxy-2-fluoro-myo-inositol to give analogues of phosphatidylinositol intermediates. Biochemical Journal 277 (2):407–12. doi: 10.1042/bj2770407.
PubMedGoogle Scholar
Mejia, C. A., P. R. Reynolds, and J. A. Arroyo. 2016. Placental expression of NFAT5, SLC5A3, and aldose reductase in gestational diabetes mellitus. The FASEB Journal 30 (851):855–851.
Google Scholar
Metzger, B. E., L. P. Lowe, A. R. Dyer, E. R. Trimble, U. Chaovarindr, D. R. Coustan, D. R. Hadden, D. R. McCance, M. Hod, H. D. McIntyre, et al. 2008. Hyperglycemia and adverse pregnancy outcomes. The New England Journal of Medicine 358 (19):1991–2002. doi: 10.1056/NEJMoa0707943.
PubMed Web of Science ®Google Scholar
Michaelis, T., G. Helms, K. D. Merboldt, W. Hänicke, H. Bruhn, and J. Frahm. 1993. Identification of scyllo‐inositol in proton NMR spectra of human brain in vivo. NMR in Biomedicine 6 (1):105–109. doi: 10.1002/nbm.1940060116.
PubMed Web of Science ®Google Scholar
Michaelis, T., G. Helms, K.-D. Merboldt, W. Hänicke, H. Bruhn, and J. Frahm. 1993. Identification of scyllo-inositol in proton NMR spectra of human brain in vivo. NMR in Biomedicine 6 (1):105–109. doi: 10.1002/nbm.1940060116.
PubMed Web of Science ®Google Scholar
Middleton, A., and B. Setchell. 1972. The origin of inositol in the rete testis fluid of the ram. Reproduction 30 (3):473–475. doi: 10.1530/jrf.0.0300473.
Web of Science ®Google Scholar
Miller, A. T., P. P. Chamberlain, and M. P. Cooke. 2008. Beyond IP3: Roles for higher order inositol phosphates in immune cell signaling. Cell Cycle (Georgetown, Tex.) 7 (4):463–7. doi: 10.4161/cc.7.4.5518.
PubMed Web of Science ®Google Scholar
Miñambres, I., G. Cuixart, A. Gonçalves, and R. Corcoy. 2019. Effects of inositol on glucose homeostasis: Systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition38 (3):1146–52. doi: 10.1016/j.clnu.2018.06.957.
PubMed Web of Science ®Google Scholar
Mitanchez, D., C. Yzydorczyk, B. Siddeek, F. Boubred, M. Benahmed, and U. Simeoni. 2015. The offspring of the diabetic mother - Short- and long-term implications. Best Practice & Research Clinical Obstetrics & Gynaecology 29 (2):256–269. doi: 10.1016/j.bpobgyn.2014.08.004.
PubMed Web of Science ®Google Scholar
Moore, C. M., J. L. Breeze, S. A. Gruber, S. M. Babb, B. B. Frederick, R. A. Villafuerte, A. L. Stoll, J. Hennen, D. A. Yurgelun-Todd, B. M. Cohen, et al. 2000. Choline, myo‐inositol and mood in bipolar disorder: A proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disorders 2 (3 Pt 2):207–16. doi: 10.1034/j.1399-5618.2000.20302.x.
PubMed Web of Science ®Google Scholar
Moore, G. J., J. M. Bebchuk, J. K. Parrish, M. W. Faulk, C. L. Arfken, J. Strahl-Bevacqua, and H. K. Manji. 1999. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. The American Journal of Psychiatry 156 (12):1902–8. doi: 10.1176/ajp.156.12.1902.
PubMed Web of Science ®Google Scholar
Mueckler, M., and B. Thorens. 2013. The SLC2 (GLUT) family of membrane transporters. Molecular Aspects of Medicine 34 (2-3):121–138. doi: 10.1016/j.mam.2012.07.001.
PubMed Web of Science ®Google Scholar
Müller, G., S. Wied, C. Piossek, A. Bauer, J. Bauer, and W. Frick. 1998. Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans. Molecular Medicine 4 (5):299–323. doi: 10.1007/BF03401738.
PubMed Web of Science ®Google Scholar
Murphy, A., A. Shamshirsaz, D. Markovic, R. Ostlund, and B. Koos. 2016. Urinary excretion of myo-inositol and d-chiro-inositol in early pregnancy is enhanced in gravidas with gestational diabetes mellitus. Reproductive Sciences (Thousand Oaks, Calif.) 23 (3):365–371. doi: 10.1177/1933719115602767.
PubMed Web of Science ®Google Scholar
Muscogiuri, G., S. Palomba, A. S. Laganà, and F. Orio. 2016. Inositols in the treatment of insulin-mediated diseases. International Journal of Endocrinology 2016:1. doi: 10.1155/2016/6189820.
Web of Science ®Google Scholar
Nagamatsu, S., and M. Ohara-Imaizumi. 2007. IP7 debut in insulin release. Science318 (5854):1249–50. doi: 10.1126/science.1151361.
PubMed Web of Science ®Google Scholar
Nakamura, J., M. A. Del Monte, D. Shewach, S. A. Lattimer, and D. A. Greene. 1992. Inhibition of phosphatidylinositol synthase by glucose in human retinal pigment epithelial cells. American Journal of Physiology-Endocrinology and Metabolism 262 (4):E417–E426. doi: 10.1152/ajpendo.1992.262.4.E417.
Google Scholar
Napso, T., H. E. J. Yong, J. Lopez-Tello, and A. N. Sferruzzi-Perri. 2018. The role of placental hormones in mediating maternal adaptations to support pregnancy and lactation. Frontiers in Physiology 9:1091 doi: 10.3389/fphys.2018.01091.
PubMed Web of Science ®Google Scholar
Nascimento, N. R., L. M. Lessa, M. R. Kerntopf, C. M. Sousa, R. S. Alves, M. G. Queiroz, J. Price, D. B. Heimark, J. Larner, X. Du, et al. 2006. Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. Proceedings of the National Academy of Sciences of the United States of America 103 (1):218–23. doi: 10.1073/pnas.0509779103.
PubMed Web of Science ®Google Scholar
Navarro-González, J. F., A. Jarque, M. Muros, C. Mora, and J. García. 2009. Tumor necrosis factor-α as a therapeutic target for diabetic nephropathy. Cytokine & Growth Factor Reviews 20 (2):165–73. doi: 10.1016/j.cytogfr.2009.02.005.
PubMed Web of Science ®Google Scholar
Nestler, J. E., and V. Unfer. 2015. Reflections on inositol(s) for PCOS therapy: Steps toward success. Gynecological Endocrinology31 (7):501–5. doi: 10.3109/09513590.2015.1054802.
PubMed Web of Science ®Google Scholar
Nestler, J. E., D. J. Jakubowicz, A. F. de Vargas, C. Brik, N. Quintero, and F. Medina. 1998. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. The Journal of Clinical Endocrinology and Metabolism 83 (6):2001–5. doi: 10.1210/jcem.83.6.4886.
PubMed Web of Science ®Google Scholar
Nestler, J. E., D. J. Jakubowicz, P. Reamer, R. D. Gunn, and G. Allan. 1999. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. New England Journal of Medicine 340 (17):1314–20. doi: 10.1056/NEJM199904293401703.
PubMed Web of Science ®Google Scholar
Newsholme, P., E. Haber, S. Hirabara, E. Rebelato, J. Procópio, D. Morgan, H. Oliveira‐Emilio, A. R. Carpinelli, and R. Curi. 2007. Diabetes associated cell stress and dysfunction: Role of mitochondrial and non‐mitochondrial ROS production and activity. The Journal of Physiology 583 (Pt 1):9–24. doi: 10.1113/jphysiol.2007.135871.
PubMed Web of Science ®Google Scholar
Nielson, J. R., and J. P. Rutter. 2018. Lipid-mediated signals that regulate mitochondrial biology. Journal of Biological Chemistry 001655
Google Scholar
Nissen, P. M., C. Nebel, N. Oksbjerg, and H. C. Bertram. 2011. Metabolomics reveals relationship between plasma inositols and birth weight: Possible markers for fetal programming of type 2 diabetes. Journal of Biomedicine and Biotechnology 2011:1–8. doi: 10.1155/2011/378268.
Google Scholar
Noble, K., J. Zhang, and S. Wray. 2006. Lipid rafts, the sarcoplasmic reticulum and uterine calcium signalling: An integrated approach. The Journal of Physiology 570 (Pt 1):29–35. doi: 10.1113/jphysiol.2005.098475.
PubMed Web of Science ®Google Scholar
Nordio, M., and E. Proietti. 2012. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. European Review for Medical and Pharmacological Sciences 16 (5):575–81.
PubMed Web of Science ®Google Scholar
Noventa, M., A. Vitagliano, M. Quaranta, S. Borgato, B. Abdulrahim, and S. Gizzo. 2016. Preventive and therapeutic role of dietary inositol supplementation in periconceptional period and during pregnancy: A summary of evidences and future applications. Reproductive Sciences (Thousand Oaks, Calif.) 23 (3):278–88. doi: 10.1177/1933719115594018.
PubMed Web of Science ®Google Scholar
Nozadze, M., E. Mikautadze, E. Lepsveridze, E. Mikeladze, N. Kuchiashvili, T. Kiguradze, M. Kikvidze, and R. Solomonia. 2011. Anticonvulsant activities of myo-inositol and scyllo-inositol on pentylenetetrazol induced seizures. Seizure20 (2):173–176. doi: 10.1016/j.seizure.2010.10.008.
PubMed Web of Science ®Google Scholar
Oben, J. A., A. Mouralidarane, A.-M. Samuelsson, P. J. Matthews, M. L. Morgan, C. McKee, J. Soeda, D. S. Fernandez-Twinn, M. S. Martin-Gronert, S. E. Ozanne, et al. 2010. Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. Journal of Hepatology 52 (6):913–20. doi: 10.1016/j.jhep.2009.12.042.
PubMed Web of Science ®Google Scholar
Ortmeyer, H. K. 1996. Dietary myoinositol results in lower urine glucose and in lower postprandial plasma glucose in obese insulin resistant rhesus monkeys. Obesity Research 4 (6):569–75. doi: 10.1002/j.1550-8528.1996.tb00271.x.
PubMedGoogle Scholar
Ortmeyer, H. K., L. C. Huang, L. Zhang, B. C. Hansen, and J. Larner. 1993. Chiroinositol deficiency and insulin resistance. II. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys. Endocrinology 132 (2):646–51. doi: 10.1210/endo.132.2.8425484.
PubMed Web of Science ®Google Scholar
Ortmeyer, H. K., N. Bodkin, K. Lilley, J. Larner, and B. C. Hansen. 1993. Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys. Endocrinology 132 (2):640–5. doi: 10.1210/endo.132.2.8425483.
PubMed Web of Science ®Google Scholar
Ostlund, R. E., J. B. McGill, I. Herskowitz, D. M. Kipnis, J. V. Santiago, and W. R. Sherman. 1993. D-chiro-inositol metabolism in diabetes mellitus. Proceedings of the National Academy of Sciences 90 (21):9988–92. doi: 10.1073/pnas.90.21.9988.
PubMed Web of Science ®Google Scholar
Owczarczyk-Saczonek, A., L. B. Lahuta, M. Ligor, W. Placek, R. J. Górecki, and B. Buszewski. 2018. The healing-promoting properties of selected cyclitols—A review. Nutrients 10 (12):1891. doi: 10.3390/nu10121891.
Web of Science ®Google Scholar
Paine, M. A., M. Scioscia, P. J. Williams, K. Gumaa, C. H. Rodeck, and T. W. Rademacher. 2010. Urinary inositol phosphoglycan P-type as a marker for prediction of preeclampsia and novel implications for the pathophysiology of this disorder. Hypertension in Pregnancy 29 (4):375–384. doi: 10.3109/10641950903242667.
PubMed Web of Science ®Google Scholar
Paine, M., C. Rodeck, P. Williams, and T. Rademacher. 2003. Possible involvement of inositol phosphoglycan-P in human parturition. Journal of Reproductive Immunology 59 (2):267–75. doi: 10.1016/S0165-0378(03)00053-6.
PubMed Web of Science ®Google Scholar
Paine, M., M. Scioscia, K. A. Gumaa, C. Rodeck, and T. Rademacher. 2006. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia. Journal of Reproductive Immunology 69 (2):165–79. doi: 10.1016/j.jri.2005.09.008.
PubMed Web of Science ®Google Scholar
Pak, Y., and J. Larner. 1992. Identification and characterization of chiroinositol-containing phospholipids from bovine liver. Biochemical and Biophysical Research Communications 184 (2):1042–7. doi: 10.1016/0006-291X(92)90696-I.
PubMed Web of Science ®Google Scholar
Pak, Y., C. R. Paule, Y.-D. Bao, L. C. Huang, and J. Larner. 1993. Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor. Proceedings of the National Academy of Sciences 90 (16):7759–7763. doi: 10.1073/pnas.90.16.7759.
PubMed Web of Science ®Google Scholar
Pak, Y., L. C. Huang, K. J. Lilley, and J. Larner. 1992. In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues. Journal of Biological Chemistry 267:16904–16910.
PubMed Web of Science ®Google Scholar
Pak, Y., Y. Hong, S. Kim, T. Piccariello, R. V. Farese, and J. Larner. 1998. Vivo chiro-Inositol Metabolism in the Rat: A Defect in chiroInositol Synthesis from myo-Inositol and an Increased Incorporation of chiro-[3H] lnositol into Phospholipid in the Goto-Kakizaki (GK) Rat. Molecules & Cells, 8. Springer Science & Business Media BV.
Google Scholar
Palmano, K., P. H. Whiting, and J. N. Hawthorne. 1977. Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin-induced diabetes. The Biochemical Journal 167 (1):229–35. doi: 10.1042/bj1670229.
PubMed Web of Science ®Google Scholar
Papaleo, E., V. Unfer, J. Baillargeon, and T. Chiu. 2009. Contribution of myo-inositol to reproduction. European Journal of Obstetrics & Gynecology and Reproductive Biology 147 (2):120–123. doi: 10.1016/j.ejogrb.2009.09.008.
PubMed Web of Science ®Google Scholar
Papaleo, E., V. Unfer, J.-P. Baillargeon, L. De Santis, F. Fusi, C. Brigante, G. Marelli, I. Cino, A. Redaelli, and A. Ferrari. 2007. Myo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation induction. Gynecological Endocrinology 23 (12):700–3. doi: 10.1080/09513590701672405.
PubMed Web of Science ®Google Scholar
Parpal, S., J. Gustavsson, and P. Strålfors. 1995. Isolation of phosphooligosaccharide/phosphoinositol glycan from caveolae and cytosol of insulin-stimulated cells. The Journal of Cell Biology 131 (1):125–135. doi: 10.1083/jcb.131.1.125.
PubMed Web of Science ®Google Scholar
Parthasarathy, R., L. Parthasarathy, and R. Vadnal. 1997. Brain inositol monophosphatase identified as a galactose 1-phosphatase. Brain Research 778 (1):99–106. doi: 10.1016/S0006-8993(97)01042-1.
PubMed Web of Science ®Google Scholar
Pascente, R., F. Frigerio, M. Rizzi, L. Porcu, M. Boido, J. Davids, M. Zaben, D. Tolomeo, M. Filibian, W. P. Gray, et al. 2016. Cognitive deficits and brain myo-Inositol are early biomarkers of epileptogenesis in a rat model of epilepsy. Neurobiology of Disease 93:146–155. doi: 10.1016/j.nbd.2016.05.001.
PubMed Web of Science ®Google Scholar
Patrussi, L., S. Mariggiò, D. Corda, and C. Baldari. 2013. The glycerophosphoinositols: From lipid metabolites to modulators of T-cell signaling. Frontiers in Immunology 4 doi: 10.3389/fimmu.2013.00213.
PubMedGoogle Scholar
Paul, C., and D. M. Brady. 2015. Inositol modulation of essential metabolic pathways of insulin resistance in metabolic syndrome, polycystic ovarian syndrome, and type 2 diabetes. Enzyme (GS) 7:16.
Google Scholar
Paulick, M. G., and C. R. Bertozzi. 2008. The Glycosylphosphatidylinositol Anchor: A Complex Membrane-Anchoring Structure for Proteins. Biochemistry 47 (27):6991–7000. doi: 10.1021/bi8006324.
PubMed Web of Science ®Google Scholar
Pedersen, J. 1952. Diabetes and pregnancy; blood sugar of newborn infants during fasting and glucose administration. Nordisk Medicin 47 (30):1049.
PubMedGoogle Scholar
Pereira, G. R., L. Baker, J. Egler, L. Corcoran, and R. Chiavacci. 1990. Serum myoinositol concentrations in premature infants fed human milk, formula for infants, and parenteral nutrition. The American Journal of Clinical Nutrition 51 (4):589–593. doi: 10.1093/ajcn/51.4.589.
PubMed Web of Science ®Google Scholar
Pérez-Pérez, A., P. Guadix, J. Maymó, J. L. Dueñas, C. Varone, M. Fernández-Sánchez, and V. Sanchez-Margalet. 2016. Insulin and leptin signaling in placenta from gestational diabetic subjects. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones et Metabolisme 48 (1):62–69. doi: 10.1055/s-0035-1559722.
PubMed Web of Science ®Google Scholar
Peters, T., B. Chapman, M. Wolfe, and M. Soares. 2000. Placental lactogen-I gene activation in differentiating trophoblast cells: Extrinsic and intrinsic regulation involving mitogen-activated protein kinase signaling pathways. The Journal of Endocrinology 165 (2):443–456. doi: 10.1677/joe.0.1650443.
PubMed Web of Science ®Google Scholar
Petit, A., G. Guillon, M. Tence, S. Jard, N. Gallo-Payet, D. Bellabarba, J. G. Lehoux, and S. Belisle. 1989. Angiotensin II stimulates both inositol phosphate production and human placental lactogen release from human trophoblastic cells. The Journal of Clinical Endocrinology and Metabolism 69 (2):280–286. doi: 10.1210/jcem-69-2-280.
PubMed Web of Science ®Google Scholar
Pettitt, T. R., S. K. Dove, A. Lubben, S. D. Calaminus, and M. J. Wakelam. 2006. Analysis of intact phosphoinositides in biological samples. Journal of Lipid Research 47 (7):1588–96. doi: 10.1194/jlr.D600004-JLR200.
PubMed Web of Science ®Google Scholar
Philipps, L., S. Santhakumaran, C. Gale, E. Prior, K. Logan, M. Hyde, and N. Modi. 2011. The diabetic pregnancy and offspring BMI in childhood: A systematic review and meta-analysis. Diabetologia 54 (8):1957–1966. doi: 10.1007/s00125-011-2180-y.
PubMed Web of Science ®Google Scholar
Pillai, R. A., Islam M. O., P. Selvam, N. Sharma, A. H. Chu, O. C. Watkins, K. M. Godfrey, R. M. Lewis, and S. Y. Chan 2020. Placental inositol reduced in gestational diabetes as glucose alters inositol transporters and IMPA1 enzyme expression. JCEM. In press
Web of Science ®Google Scholar
Pintaudi, B., G. Di Vieste, and M. Bonomo. 2016. The effectiveness of myo-inositol and D-chiro inositol treatment in type 2 diabetes. International Journal of Endocrinology 2016:1–5. doi: 10.1155/2016/9132052.
Web of Science ®Google Scholar
Plows, J. F., F. Budin, R. A. Andersson, V. J. Mills, K. Mace, S. T. Davidge, M. H. Vickers, P. N. Baker, I. Silva-Zolezzi, and J. L. Stanley. 2017. The effects of myo-inositol and B and D vitamin supplementation in the db/+ mouse model of gestational diabetes mellitus. Nutrients 9 (2):141. doi: 10.3390/nu9020141.
PubMed Web of Science ®Google Scholar
Plows, J., J. R. Nieves, F. Budin, K. Mace, C. Reynolds, M. Vickers, I. Silva-Zolezzi, P. Baker, and J. Stanley. 2020. The effects of myo-inositol and probiotic supplementation in a high fat fed preclinical model of glucose intolerance in pregnancy. British Journal of Nutrition 123 (5):516–39. doi: 10.1017/S0007114519003039.
PubMed Web of Science ®Google Scholar
Poston, L., R. Bell, H. Croker, A. C. Flynn, K. M. Godfrey, L. Goff, L. Hayes, N. Khazaezadeh, S. M. Nelson, E. Oteng-Ntim, et al. 2015. Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): A multicentre, randomised controlled trial. The Lancet. Diabetes & Endocrinology 3 (10):767–777. doi: 10.1016/S2213-8587(15)00227-2.
PubMed Web of Science ®Google Scholar
Prynne, C. J., A. McCarron, M. E. Wadsworth, and A. M. Stephen. 2010. Dietary fibre and phytate–a balancing act: Results from three time points in a British Birth Cohort. British Journal of Nutrition 103 (2):274–80. doi: 10.1017/S0007114509991644.
PubMed Web of Science ®Google Scholar
Pugliese, G., R. G. Tilton, A. Speedy, E. Santarelli, D. M. Eades, M. A. Province, C. Kilo, W. R. Sherman, and J. R. Williamson. 1990. Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol. Diabetes 39 (3):312–22. doi: 10.2337/diab.39.3.312.
PubMed Web of Science ®Google Scholar
Pundir, J., D. Psaroudakis, P. Savnur, P. Bhide, L. Sabatini, H. Teede, A. Coomarasamy, and S. Thangaratinam. 2018. Inositol treatment of anovulation in women with polycystic ovary syndrome: A meta‐analysis of randomised trials. BJOG: An International Journal of Obstetrics & Gynaecology 125 (3):299–308. doi: 10.1111/1471-0528.14754.
PubMedGoogle Scholar
Quirk, J. G., Jr., and J. E. Bleasdale. 1983. myo-Inositol homeostasis in the human fetus. Obstetrics and Gynecology 62 (1):41–44.
PubMed Web of Science ®Google Scholar
Rajasekaran, S. S., J. Kim, G.-C. Gaboardi, J. Gromada, S. B. Shears, K. T. dos Santos, E. L. Nolasco, S. d S. Ferreira, C. Illies, M. Köhler, et al. 2018. Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic β-cells. Cellular Signalling 46:120–8. doi: 10.1016/j.cellsig.2018.03.001.
PubMed Web of Science ®Google Scholar
Reeves, V. L., C. M. Thomas, and E. J. Smart. 2012. Lipid rafts, caveolae and GPI-linked proteins, 3–13. Caveolins and Caveolae: Springer.
Google Scholar
Regidor, P.-A., A. E. Schindler, B. Lesoine, and R. Druckman. 2018. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. Hormone Molecular Biology and Clinical Investigation 0 (0) doi: 10.1515/hmbci-2017-0067.
Google Scholar
Roach, J. C., K. Deutsch, S. Li, A. F. Siegel, L. M. Bekris, D. C. Einhaus, C. M. Sheridan, G. Glusman, L. Hood, A. Lernmark, et al. 2006. Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. American Journal of Human Genetics 79 (4):614–27., doi: 10.1086/507876.
PubMed Web of Science ®Google Scholar
Roll, P., A. Massacrier, S. Pereira, A. Robaglia-Schlupp, P. Cau, and P. Szepetowski. 2002. New human sodium/glucose cotransporter gene (KST1): Identification, characterization, and mutation analysis in ICCA (infantile convulsions and choreoathetosis) and BFIC (benign familial infantile convulsions) families. Gene 285 (1-2):141–148. doi: 10.1016/S0378-1119(02)00416-X.
PubMed Web of Science ®Google Scholar
Romero, G., and J. Larner. 1993. Insulin mediators and the mechanism of insulin action. Advances in pharmacology. Vol 24, 21–50. Elsevier.
Google Scholar
Rubin, L. J., and C. C. Hale. 1993. Characterization of a Mg-dependent, Na-inositol Co-transport process in cardiac sarcolemmal vesicles. Journal of Molecular and Cellular Cardiology 25 (6):721–731. doi: 10.1006/jmcc.1993.1084.
PubMed Web of Science ®Google Scholar
Ruchat, S. M., M. F. Hivert, and L. Bouchard. 2013. Epigenetic programming of obesity and diabetes by in utero exposure to gestational diabetes mellitus. Nutrition Reviews 71 (Suppl 1):S88–S94. doi: 10.1111/nure.12057.
PubMedGoogle Scholar
Sacks, D. A., D. R. Hadden, M. Maresh, C. Deerochanawong, A. R. Dyer, B. E. Metzger, L. P. Lowe, D. R. Coustan, M. Hod, J. J. Oats, et al. 2012. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 35 (3):526–528. doi: 10.2337/dc11-1641.
PubMed Web of Science ®Google Scholar
Salman, M., J. T. Lonsdale, G. S. Besra, and P. J. Brennan. 1999. Phosphatidylinositol synthesis in mycobacteria. Biochimica et Biophysica Acta 1436 (3):437–450. doi: 10.1016/S0005-2760(98)00151-9.
PubMed Web of Science ®Google Scholar
Saltiel, A. R. 1990. Second messengers of insulin action. Diabetes Care 13 (3):244–56. doi: 10.2337/diacare.13.3.244.
PubMed Web of Science ®Google Scholar
Sampson, M., M. Wolf, R. Thadhani, J. L. Ecker, E. W. Seely, C. Lam, S. A. Karumanchi, V. P. Sukhatme, A. S. M. Shakir, A. Daftary, et al. 2004. Preeclampsia and future cardiovascular disease: Potential role of altered angiogenesis and insulin resistance. The Journal of Clinical Endocrinology & Metabolism 89 (12):6239–6243. doi: 10.1210/jc.2004-0548.
PubMed Web of Science ®Google Scholar
Santamaria, A., A. Alibrandi, A. Di Benedetto, B. Pintaudi, F. Corrado, F. Facchinetti, and R. D’Anna. 2018. Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: A secondary analysis from 3 RCTs. American Journal of Obstetrics and Gynecology 219 (3):300.e1–300.e6. doi: 10.1016/j.ajog.2018.05.018.
Web of Science ®Google Scholar
Santamaria, A., A. Di Benedetto, E. Petrella, B. Pintaudi, F. Corrado, R. D’Anna, I. Neri, and F. Facchinetti. 2016. Myo-inositol may prevent gestational diabetes onset in overweight women: A randomized, controlled trial. The Journal of Maternal-Fetal & Neonatal Medicine 29 (19):3234–3237. doi: 10.3109/14767058.2015.1121478.
PubMed Web of Science ®Google Scholar
Santamaria, A., D. Giordano, F. Corrado, B. Pintaudi, M. Interdonato, G. D. Vieste, A. D. Benedetto, and R. D'Anna. 2012. One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. Climacteric15 (5):490–495. doi: 10.3109/13697137.2011.631063.
PubMed Web of Science ®Google Scholar
Santamaria, A., F. Corrado, G. Baviera, G. Carlomagno, V. Unfer, and R. D’anna. 2016. Second trimester amniotic fluid myo-inositol concentrations in women later developing gestational diabetes mellitus or pregnancy-induced hypertension. The Journal of Maternal-Fetal & Neonatal Medicine 29 (14):2245–2247. doi: 10.3109/14767058.2015.1081886.
PubMed Web of Science ®Google Scholar
Santamaria, A., F. Corrado, M. L. Interdonato, G. Baviera, G. Carlomagno, P. Cavalli, V. Unfer, and R. D'Anna. 2014. Myo-inositol in Down syndrome amniotic fluid. A case-control study. Prenatal Diagnosis 34 (9):917–8. doi: 10.1002/pd.4398.
PubMed Web of Science ®Google Scholar
Satake, W., Y. Nakabayashi, I. Mizuta, Y. Hirota, C. Ito, M. Kubo, T. Kawaguchi, T. Tsunoda, M. Watanabe, A. Takeda, et al. 2009. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinsons disease. Nature Genetics 41 (12):1303–1307. doi: 10.1038/ng.485.
PubMed Web of Science ®Google Scholar
Sayers, N., and A. C. Hanyaloglu. 2018. Intracellular follicle-stimulating hormone receptor trafficking and signaling. Frontiers in Endocrinology 9:653. doi: 10.3389/fendo.2018.00653.
PubMed Web of Science ®Google Scholar
Schaefer, ‐Graf, U., Meitzner, K. Ortega,‐Senovilla, H. Graf, K. Vetter, K. Abou‐Dakn, M. Herrera. and E. 2011. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabetic Medicine 28 (9):1053–1059. doi: 10.1111/j.1464-5491.2011.03346.x.
PubMed Web of Science ®Google Scholar
Schaefer-Graf, U. M., K. Graf, I. Kulbacka, S. L. Kjos, J. Dudenhausen, K. Vetter, and E. Herrera. 2008. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 31 (9):1858–1863. doi: 10.2337/dc08-0039.
PubMed Web of Science ®Google Scholar
Schlemmer, U., W. Frølich, R. M. Prieto, and F. Grases. 2009. Phytate in foods and significance for humans: Food sources, intake, processing, bioavailability, protective role and analysis. Molecular Nutrition & Food Research 53 (S2):S330–S375. doi: 10.1002/mnfr.200900099.
PubMedGoogle Scholar
Schneider, S. 2015. Inositol transport proteins. FEBS Letters 589 (10):1049–1058. doi: 10.1016/j.febslet.2015.03.012.
PubMed Web of Science ®Google Scholar
Schrey, M. P., A. M. Read, and P. J. Steer. 1987. Stimulation of phospholipid hydrolysis and arachidonic acid mobilization in human uterine decidua cells by phorbol ester. The Biochemical Journal 246 (3):705–713. doi: 10.1042/bj2460705.
PubMed Web of Science ®Google Scholar
Schrey, M. P., J. R. Holt, P. A. Cornford, H. Monaghan, and F. Al-Ubaidi. 1992. Human decidua is a target tissue for bradykinin and kallikrein: Phosphoinositide hydrolysis accompanies arachidonic acid release in uterine decidua cells in vitro. The Journal of clinical Endocrinology and Metabolism 74 (2):426–435. doi: 10.1210/jcem.74.2.1309839.
PubMed Web of Science ®Google Scholar
Schwartz, R., P. A. Gruppuso, K. Petzold, D. Brambilla, V. Hiilesmaa, and K. A. Teramo. 1994. Hyperinsulinemia and macrosomia in the fetus of the diabetic mother. Diabetes Care 17 (7):640–648. doi: 10.2337/diacare.17.7.640.
PubMed Web of Science ®Google Scholar
Scioscia, M. 2017. D-chiro inositol phosphoglycans in preeclampsia: Where are we, where are we going? Journal of Reproductive Immunology 124:1–7. doi: 10.1016/j.jri.2017.09.010.
PubMed Web of Science ®Google Scholar
Scioscia, M., A. Pesci, G. Zamboni, B. Huppertz, and L. Resta. 2013. D-chiro-inositol phosphoglycan expression in human placenta at term in diabetes. Archives of Gynecology and Obstetrics 288 (2):459–60. doi: 10.1007/s00404-013-2729-8.
PubMed Web of Science ®Google Scholar
Scioscia, M., K. Gumaa, and T. W. Rademacher. 2009. The link between insulin resistance and preeclampsia: New perspectives. Journal of Reproductive Immunology 82 (2):100–5. doi: 10.1016/j.jri.2009.04.009.
PubMed Web of Science ®Google Scholar
Scioscia, M., K. Gumaa, L. E. Selvaggi, C. H. Rodeck, and T. W. Rademacher. 2009. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus. Journal of Perinatal Medicine 37 (5):469–471. doi: 10.1515/JPM.2009.082.
PubMed Web of Science ®Google Scholar
Scioscia, M., K. Gumaa, M. Whitten, L. E. Selvaggi, C. H. Rodeck, and T. W. Rademacher. 2007. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies. Journal of Reproductive Immunology 76 (1-2):85–90. doi: 10.1016/j.jri.2007.03.016.
PubMed Web of Science ®Google Scholar
Scioscia, M., K. Gumaa, S. Kunjara, M. A. Paine, L. E. Selvaggi, C. H. Rodeck, and T. W. Rademacher. 2006. Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and-2. The Journal of Clinical Endocrinology & Metabolism 91 (2):709–17. doi: 10.1210/jc.2005-1965.
PubMed Web of Science ®Google Scholar
Scioscia, M., M. A. Paine, K. Gumaa, C. H. Rodeck, and T. W. Rademacher. 2008. Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: A multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension. The Journal of Maternal-Fetal & Neonatal Medicine 21 (8):581–5. doi: 10.1080/14767050802199934.
PubMed Web of Science ®Google Scholar
Scioscia, M., P. J. Williams, K. Gumaa, N. Fratelli, C. Zorzi, and T. W. Rademacher. 2011. Inositol phosphoglycans and preeclampsia: From bench to bedside. Journal of Reproductive Immunology 89 (2):173–177. doi: 10.1016/j.jri.2011.03.001.
PubMed Web of Science ®Google Scholar
Scioscia, M., S. Kunjara, K. Gumaa, A. M. Gomez Galan, P. McLean, C. H. Rodeck, and T. W. Rademacher. 2007. Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. Gynecologic and Obstetric Investigation 64 (4):217–23. doi: 10.1159/000106494.
PubMed Web of Science ®Google Scholar
Scioscia, M., S. Kunjara, K. Gumaa, P. McLean, C. Rodeck, and T. Rademacher. 2007. Urinary excretion of inositol phosphoglycan P‐type in gestational diabetes mellitus. Diabetic Medicine 24 (11):1300–1304. doi: 10.1111/j.1464-5491.2007.02267.x.
PubMed Web of Science ®Google Scholar
Seaquist, E. R., and R. Gruetter. 1998. Identification of a high concentration of scyllo-inositol in the brain of a healthy human subject using 1H- and 13C-NMR . Magnetic Resonance in Medicine 39 (2):313–316. doi: 10.1002/mrm.1910390220.
PubMed Web of Science ®Google Scholar
Seely, E. W., and C. G. Solomon. 2003. Insulin resistance and its potential role in pregnancy-induced hypertension. The Journal of Clinical Endocrinology and Metabolism 88 (6):2393–2398. doi: 10.1210/jc.2003-030241.
PubMed Web of Science ®Google Scholar
Shaldubina, A., R. Buccafusca, R. Johanson, G. Agam, R. Belmaker, G. Berry, and Y. Bersudsky. 2007. Behavioural phenotyping of sodium‐myo‐inositol cotransporter heterozygous knockout mice with reduced brain inositol. Genes, Brain and Behavior 6 (3):253–259. doi: 10.1111/j.1601-183X.2006.00253.x.
PubMed Web of Science ®Google Scholar
Sharma, K., L. Wang, Y. Zhu, A. DeGuzman, G.-Y. Cao, R. B. Lynn, and S. K. Joseph. 1999. Renal type I inositol 1, 4, 5-trisphosphate receptor is reduced in streptozotocin-induced diabetic rats and mice. American Journal of Physiology-Renal Physiology 276 (1):F54–F61. doi: 10.1152/ajprenal.1999.276.1.F54.
Web of Science ®Google Scholar
Shears, S. B. 2015. Inositol pyrophosphates: Why so many phosphates? Advances in Biological Regulation 57:203–16. doi: 10.1016/j.jbior.2014.09.015.
PubMedGoogle Scholar
Sherman, W. R., M. A. Stewart, M. M. Kurien, and S. L. Goodwin. 1968. The measurement of myo-inositol, myo-inosose-2 and scyllo-inositol in mammalian tissues. Biochimica et Biophysica Acta (Bba) - General Subjects 158 (2):197–205. doi: 10.1016/0304-4165(68)90131-1.
PubMedGoogle Scholar
Sherman, W. R., M. A. Stewart, P. C. Simpson, and S. L. Goodwin. 1968. The identification of myo-inosose-2 and scyllo-inositol in mammalian tissues. Biochemistry 7 (2):819–824. doi: 10.1021/bi00842a040.
PubMed Web of Science ®Google Scholar
Sherman, W. R., S. L. Goodwin, and K. D. Gunnell. 1971. neo-Inositol in mammalian tissues. Identification, measurement, and enzymic synthesis from mannose 6-phosphate. Biochemistry 10 (19):3491–3499. doi: 10.1021/bi00795a002.
PubMed Web of Science ®Google Scholar
Shewan, A., D. J. Eastburn, and K. Mostov. 2011. Phosphoinositides in cell architecture. Cold Spring Harbor Perspectives in Biology 3 (8):a004796. doi: 10.1101/cshperspect.a004796.
PubMed Web of Science ®Google Scholar
Shimon, H., Y. Sobolev, M. Davidson, V. Haroutunian, R. H. Belmaker, and G. Agam. 1998. Inositol levels are decreased in postmortem brain of schizophrenic patients. Biological Psychiatry 44 (6):428–432. doi: 10.1016/S0006-3223(98)00071-7.
PubMed Web of Science ®Google Scholar
Shin, J.-A., H.-M. Kwon, K.-H. Han, and H.-Y. Lee. 2012. TonEBP and SMIT expression in human placenta. Anatomy & Cell Biology 45 (3):155–159. doi: 10.5115/acb.2012.45.3.155.
PubMedGoogle Scholar
Siddle, K. 2011. Signalling by insulin and IGF receptors: Supporting acts and new players. Journal of Molecular Endocrinology 47 (1):R1–R10. doi: 10.1530/JME-11-0022.
PubMed Web of Science ®Google Scholar
Silverstone, P. H., B. M. McGrath, and H. Kim. 2005. Bipolar disorder and myo‐inositol: A review of the magnetic resonance spectroscopy findings. Bipolar Disorders 7 (1):1–10. doi: 10.1111/j.1399-5618.2004.00174.x.
PubMed Web of Science ®Google Scholar
Simons, K., and R. Ehehalt. 2002. Cholesterol, lipid rafts, and disease. The Journal of Clinical Investigation 110 (5):597–603. doi: 10.1172/JCI16390.
PubMed Web of Science ®Google Scholar
Soeda, Y., H. Tsuneki, H. Muranaka, N. Mori, S. Hosoh, Y. Ichihara, S. Kagawa, X. Wang, N. Toyooka, Y. Takamura, et al. 2010. The inositol phosphatase SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain. Molecular Endocrinology (Baltimore, Md.) 24 (10):1965–77. doi: 10.1210/me.2010-0163.
PubMedGoogle Scholar
Solomonia, R., E. Mikautadze, M. Nozadze, N. Kuchiashvili, E. Lepsveridze, and T. Kiguradze. 2010. Myo-inositol treatment prevents biochemical changes triggered by kainate-induced status epilepticus. Neuroscience Letters 468 (3):277–81. doi: 10.1016/j.neulet.2009.11.012.
PubMed Web of Science ®Google Scholar
Staat, B. C., H. L. Galan, J. E. Harwood, G. Lee, A. M. Marconi, C. L. Paolini, A. Cheung, and F. C. Battaglia. 2012. Transplacental supply of mannose and inositol in uncomplicated pregnancies using stable isotopes. The Journal of Clinical Endocrinology and Metabolism 97 (7):2497–2502. doi: 10.1210/jc.2011-1800.
PubMed Web of Science ®Google Scholar
Stamler, C. J., D. Breznan, T. A. Neville, F. J. Viau, E. Camlioglu, and D. L. Sparks. 2000. Phosphatidylinositol promotes cholesterol transport in vivo. Journal of Lipid Research 41 (8):1214–21.
PubMed Web of Science ®Google Scholar
Stanirowski, P. J., D. Szukiewicz, M. Pyzlak, N. Abdalla, W. Sawicki, and K. Cendrowski. 2017. Impact of pre-gestational and gestational diabetes mellitus on the expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 in human term placenta. Endocrine 55 (3):799–808. doi: 10.1007/s12020-016-1202-4.
PubMed Web of Science ®Google Scholar
Steegers-Theunissen, R., P. Groenen, and P. Beemster. 2002. Involvement of Inositol in Reproduction. Nutrition Reviews 60 (3):80–87. doi: 10.1301/00296640260042748.
PubMed Web of Science ®Google Scholar
Steer, T. E., and G. R. Gibson. 2002. The microbiology of phytic acid metabolism by gut bacteria and relevance for bowel cancer. International Journal of Food Science and Technology 37 (7):783–90. doi: 10.1046/j.1365-2621.2002.00616.x.
Web of Science ®Google Scholar
Stewart, M. A., W. R. Sherman, and J. T. Harris. 1970. Effects of galactose on levels of free myo‐inositol in rat tissues. Annals of the New York Academy of Sciences 165:609–614.
Web of Science ®Google Scholar
Stokes, C. E., and J. N. Hawthorne. 1987. Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains. Journal of Neurochemistry 48 (4):1018–1021. doi: 10.1111/j.1471-4159.1987.tb05619.x.
PubMed Web of Science ®Google Scholar
Stokes, C. E., K. R. W. Gillon, and J. N. Hawthorne. 1983. Free and total lipid myo-inositol concentrations decrease with age in human brain. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 753 (1):136–138. doi: 10.1016/0005-2760(83)90108-X.
PubMed Web of Science ®Google Scholar
Strange, K., F. Emma, A. Paredes, and R. Morrison. 1994. Osmoregulatory changes in Myo-inositol content and Na+/Myo-inositol contransport in rat cortical astrocytes. Glia 12 (1):35–43. doi: 10.1002/glia.440120105.
PubMedGoogle Scholar
Strieleman, P. J., M. A. Connors, and B. E. Metzger. 1992. Phosphoinositide metabolism in the developing conceptus. Effects of hyperglycemia and scyllo-inositol in rat embryo culture. Diabetes 41 (8):989–997. doi: 10.2337/diab.41.8.989.
PubMed Web of Science ®Google Scholar
Strieleman, P., and B. E. Metzger. 1993. Glucose and scyllo-inositol impair phosphoinositide hydrolysis in the 10.5-day cultured rat conceptus: a role in dysmorphogenesis? Teratology 48 (3):267–278. doi: 10.1002/tera.1420480310.
PubMedGoogle Scholar
Strieleman, P., M. Connors, and B. E. Metzger. 1992. Phosphoinositide metabolism in the developing conceptus: Effects of hyperglycemia and scyllo-inositol in rat embryo culture. Diabetes 41 (8):989–997. doi: 10.2337/diab.41.8.989.
PubMed Web of Science ®Google Scholar
Stull, A. J., J. P. Thyfault, M. D. Haub, R. E. Ostlund, Jr, and W. W. Campbell. 2008. Relationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation. Metabolism 57 (11):1545–1551. doi: 10.1016/j.metabol.2008.06.009.
PubMed Web of Science ®Google Scholar
Sun, T-H, D. B. Heimark, T. Nguygen, J. L. Nadler, and J. Larner. 2002. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. Biochemical and Biophysical Research Communications 293 (3):1092–8. doi: 10.1016/S0006-291X(02)00313-3.
PubMed Web of Science ®Google Scholar
Sussman, I., and F. M. Matschinsky. 1988. Diabetes affects sorbitol and myo-inositol levels of neuroectodermal tissue during embryogenesis in rat. Diabetes 37 (7):974–981. doi: 10.2337/diab.37.7.974.
PubMed Web of Science ®Google Scholar
Suzuki, S.,. C. Suzuki, Y. Hinokio, Y. Ishigaki, H. Katagiri, M. Kanzaki, V. N. Azev, N. Chakraborty, and M. d'Alarcao. 2014. Insulin-mimicking bioactivities of acylated inositol glycans in several mouse models of diabetes with or without obesity. PloS One 9 (6):e100466. doi: 10.1371/journal.pone.0100466.
PubMed Web of Science ®Google Scholar
Suzuki, S.,. H. Kawasaki, Y. Satoh, M. Ohtomo, M. Hirai, A. Hirai, S. Hirai, M. Onoda, M. Matsumoto, Y. Hinokio, et al. 1994. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. Diabetes Care 17 (12):1465–8., doi: 10.2337/diacare.17.12.1465.
PubMed Web of Science ®Google Scholar
Suzuki, S.,. Y. Taneda, S. Hirai, S. Abe, A. Sasaki, K-I Suzuki, and T. Toyota. 1991. Molecular mechanism of insulin resistance in spontaneous diabetic GK (Goto-Kakizaki) rats. New Directions in Research and Clinical Works for. Obesity and Diabetes Mellitus :197–203.
Google Scholar
Sweeting, A. N., G. P. Ross, J. Hyett, L. Molyneaux, M. Constantino, A. J. Harding, and J. Wong. 2016. Gestational diabetes mellitus in early pregnancy: Evidence for poor pregnancy outcomes despite treatment. Diabetes Care 39 (1):75–81. doi: 10.2337/dc15-0433.
PubMed Web of Science ®Google Scholar
Tabrizi, R., V. Ostadmohammadi, K. B. Lankarani, P. Peymani, M. Akbari, F. Kolahdooz, and Z. Asemi. 2018. The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Lipids in Health and Disease 17 (1):123. doi: 10.1186/s12944-018-0779-4.
PubMedGoogle Scholar
Taguchi, R., J. Yamazaki, Y. Tsutsui, and H. Ikezawa. 1997. Identification of chiro-inositol and its formation by isomerization of myo-inositol during hydrolysis of glycosylphosphatidylinositol-anchored proteins. Archives of Biochemistry and Biophysics 342 (1):161–168. doi: 10.1006/abbi.1997.9991.
PubMed Web of Science ®Google Scholar
Tessier, D., Z. Ferraro, and A. Gruslin. 2013. Role of leptin in pregnancy: Consequences of maternal obesity. Placenta 34 (3):205–211. doi: 10.1016/j.placenta.2012.11.035.
PubMed Web of Science ®Google Scholar
Thomas, M. P., S. J. Mills, and B. V. L. Potter. 2016. The “Other” Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry). Angewandte Chemie (International ed. In English) 55 (5):1614–1650. doi: 10.1002/anie.201502227.
PubMed Web of Science ®Google Scholar
Thomas, T. P., E. L. Feldman, J. Nakamura, K. Kato, M. Lien, M. J. Stevens, and D. A. Greene. 1993. Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture. Proceedings of the National Academy of Sciences 90 (20):9712–6. doi: 10.1073/pnas.90.20.9712.
PubMed Web of Science ®Google Scholar
Thomas, T. P., F. Porcellati, K. Kato, M. J. Stevens, W. R. Sherman, and D. A. Greene. 1994. Effects of glucose on sorbitol pathway activation, cellular redox, and metabolism of myo-inositol, phosphoinositide, and diacylglycerol in cultured human retinal pigment epithelial cells. The Journal of Clinical Investigation 93 (6):2718–24. doi: 10.1172/JCI117286.
PubMed Web of Science ®Google Scholar
Thurston, J. H., W. R. Sherman, R. E. Hauhart, and R. F. Kloepper. 1989. myo-Inositol: A Newly Identified Nonnitrogenous Osmoregulatory Molecule in Mammalian Brain. Pediatric Research 26 (5):482–485. doi: 10.1203/00006450-198911000-00024.
PubMed Web of Science ®Google Scholar
Toh, N., T. Inoue, H. Tanaka, and E. Kimoto. 1987. Polyol accumulation in human placenta and umbilical cord. Biological Research in Pregnancy and Perinatology 8 (1 1ST Half):13–15.
PubMedGoogle Scholar
Tominaga, T.,. R. K. Dutta, D. Joladarashi, T. Doi, J. K. Reddy, and Y. S. Kanwar. 2016. Transcriptional and translational modulation of myo-inositol oxygenase (Miox) by fatty acids Implications in renal tubular injury induced in obesity and diabetes. The Journal of Biological Chemistry 291 (3):1348–67. doi: 10.1074/jbc.M115.698191.
PubMed Web of Science ®Google Scholar
Trama, J., Q. Lu, R. G. Hawley, and S. N. Ho. 2000. The NFAT-related protein NFATL1 (TonEBP/NFAT5) is induced upon T cell activation in a calcineurin-dependent manner. The Journal of Immunology 165 (9):4884–4894. doi: 10.4049/jimmunol.165.9.4884.
PubMed Web of Science ®Google Scholar
Traynor-Kaplan, A., M. Kruse, E. J. Dickson, G. Dai, O. Vivas, H. Yu, D. Whittington, and B. Hille. 2017. Fatty-acyl chain profiles of cellular phosphoinositides. Biochimica et Biophysica Acta (Bba) - Molecular and Cell Biology of Lipids 1862 (5):513–22. doi: 10.1016/j.bbalip.2017.02.002.
PubMed Web of Science ®Google Scholar
Trocino, R. A., S. Akazawa, M. Ishibashi, K. Matsumoto, H. Matsuo, H. Yamamoto, S. Goto, Y. Urata, T. Kondo, and S. Nagataki. 1995. Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44 (8):992–8. doi: 10.2337/diab.44.8.992.
PubMed Web of Science ®Google Scholar
Troyer, D., D. Schwertz, J. Kreisberg, and M. A. Venkatachalam. 1986. Inositol phospholipid metabolism in the kidney. Annual Review of Physiology 48:51–71. doi: 10.1146/annurev.ph.48.030186.000411.
PubMed Web of Science ®Google Scholar
Tsai, Y.-H., X. Liu, and P. H. Seeberger. 2012. Chemical biology of glycosylphosphatidylinositol anchors. Angewandte Chemie (International ed. In English) 51 (46):11438–56. doi: 10.1002/anie.201203912.
PubMed Web of Science ®Google Scholar
Turner, D. I., N. Chakraborty, and M. d'Alarcao. 2005. A fluorescent inositol phosphate glycan stimulates lipogenesis in rat adipocytes by extracellular activation alone. Bioorganic & Medicinal Chemistry Letters 15 (8):2023–5. doi: 10.1016/j.bmcl.2005.02.061.
PubMed Web of Science ®Google Scholar
Uhl, O., H. Demmelmair, M. T. Segura, J. Florido, R. Rueda, C. Campoy, and B. Koletzko. 2015. Effects of obesity and gestational diabetes mellitus on placental phospholipids. Diabetes Research and Clinical Practice 109 (2):364–371. doi: 10.1016/j.diabres.2015.05.032.
PubMed Web of Science ®Google Scholar
Unfer, V., and G. Porcaro. 2014. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. Expert Review of Clinical Pharmacology 7 (5):623–31. doi: 10.1586/17512433.2014.925795.
PubMed Web of Science ®Google Scholar
Unfer, V., F. Facchinetti, B. Orrù, B. Giordani, and J. Nestler. 2017. Myo-inositol effects in women with PCOS: A meta-analysis of randomized controlled trials. Endocrine Connections 6 (8):647–658. doi: 10.1530/EC-17-0243.
PubMed Web of Science ®Google Scholar
Unfer, V., G. Carlomagno, G. Dante, and F. Facchinetti. 2012. Effects of myo-inositol in women with PCOS: A systematic review of randomized controlled trials. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology 28 (7):509–15. doi: 10.3109/09513590.2011.650660.
PubMed Web of Science ®Google Scholar
Valluru, R., and W. Van den Ende. 2011. Myo-inositol and beyond-emerging networks under stress. Plant Science: An International Journal of Experimental Plant Biology 181 (4):387–400. doi: 10.1016/j.plantsci.2011.07.009.
PubMed Web of Science ®Google Scholar
Van Sande, J., D. Dequanter, P. Lothaire, C. Massart, J. E. Dumont, and C. Erneux. 2006. Thyrotropin stimulates the generation of inositol 1, 4, 5-trisphosphate in human thyroid cells. The Journal of Clinical Endocrinology and Metabolism 91 (3):1099–107. doi: 10.1210/jc.2005-1324.
PubMed Web of Science ®Google Scholar
Varela-Nieto, I., Y. León, and H. N. Caro. 1996. Cell signalling by inositol phosphoglycans from different species. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 115 (2):223–41. doi: 10.1016/0305-0491(96)00087-9.
PubMed Web of Science ®Google Scholar
Vernon, D. M., and H. J. Bohnert. 1992. A novel methyl transferase induced by osmotic stress in the facultative halophyte Mesembryanthemum crystallinum. The EMBO Journal 11 (6):2077–85. doi: 10.1002/j.1460-2075.1992.tb05266.x.
PubMed Web of Science ®Google Scholar
Vernon, R. G. 2005. Lipid metabolism during lactation: A review of adipose tissue-liver interactions and the development of fatty liver. The Journal of Dairy Research 72 (4):460–9. doi: 10.1017/S0022029905001299.
PubMed Web of Science ®Google Scholar
Villalba, M., K. L. Kelly, and J. M. Mato. 1988. Inhibition of cyclic AMP-dependent protein kinase by the polar head group of an insulin-sensitive glycophospholipid. Biochimica et Biophysica Acta (Bba) - Molecular Cell Research 968 (1):69–76. doi: 10.1016/0167-4889(88)90045-6.
PubMedGoogle Scholar
Vinggaard, A. M., and H. S. Hansen. 1995. Characterization and partial purification of phospholipase D from human placenta. Biochimica et Biophysica Acta 1258 (2):169–176. doi: 10.1016/0005-2760(95)00121-R.
PubMedGoogle Scholar
Vitagliano, A., G. Saccone, E. Cosmi, S. Visentin, F. Dessole, G. Ambrosini, and V. Berghella. 2019. Inositol for the prevention of gestational diabetes: A systematic review and meta-analysis of randomized controlled trials. Archives of Gynecology and Obstetrics 299 (1):55–68. doi: 10.1007/s00404-018-5005-0.
PubMed Web of Science ®Google Scholar
Vivien, D., E. Petitfrère, L. Martiny, H. Sartelet, P. Galéra, B. Haye, and J.-P. Pujol. 1993. IPG (inositolphosphate glycan) as a cellular signal for TGF-β1 modulation of chondrocyte cell cycle. Journal of Cellular Physiology 155 (3):437–44. doi: 10.1002/jcp.1041550302.
PubMed Web of Science ®Google Scholar
Voglmayr, J., and I. White. 1971. Synthesis and metabolism of myoinositol in testicular and ejaculated spermatozoa of the ram. Journal of Reproduction and Fertility 24 (1):29–37. doi: 10.1530/jrf.0.0240029.
PubMedGoogle Scholar
Walsh, S. W., and V. M. Parisi. 1986. The role of arachidonic acid metabolites in preeclampsia. Paper presented at: Seminars in perinatology.
Google Scholar
Wang, X., S. P. Devaiah, W. Zhang, and R. Welti. 2006. Signaling functions of phosphatidic acid. Progress in Lipid Research 45 (3):250–278. doi: 10.1016/j.plipres.2006.01.005.
PubMed Web of Science ®Google Scholar
Watkins, O. C., M. O. Islam, P. Selvam, R. A. Pillai, A. Cazenave-Gassiot, A. K. Bendt, N. Karnani, K. M. Godfrey, R. M. Lewis, M. R. Wenk, et al. 2019. Inositol alters 13C-labeled fatty acid metabolism in human placental explants. Journal of Endocrinology 243 (1):73–84., doi: 10.1530/JOE-19-0267.
Web of Science ®Google Scholar
Wells, I. C., and J. Hogan. 1968. Effects of dietary deficiencies of lipotropic factors on plasma cholesterol esterification and tissue cholesterol in rats. The Journal of Nutrition 95 (1):55–62. doi: 10.1093/jn/95.1.55.
PubMed Web of Science ®Google Scholar
Wells, W. W., T. A. Pittman, and H. J. Wells. 1965. Quantitative analysis of myoinositol in rat tissue by gas-liquid chromatography. Analytical Biochemistry 10 (3):450–458. doi: 10.1016/0003-2697(65)90314-3.
Web of Science ®Google Scholar
Wenk, M. R., L. Lucast, G. Di Paolo, A. J. Romanelli, S. F. Suchy, R. L. Nussbaum, G. W. Cline, G. I. Shulman, W. McMurray, and P. De Camilli. 2003. Phosphoinositide profiling in complex lipid mixtures using electrospray ionization mass spectrometry. Nature Biotechnology 21 (7):813–7. doi: 10.1038/nbt837.
PubMed Web of Science ®Google Scholar
Wentzel, P., and U. J. Eriksson. 2020. Embryopathy and Diabetes. Gestational Diabetes. Vol 28: Karger Publishers; 132–44.
Google Scholar
Wentzel, P., C. R. Wentzel, M. B. Gäreskog, and U. J. Eriksson. 2001. Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity. Teratology 63 (5):193–201. doi: 10.1002/tera.1034.
PubMedGoogle Scholar
Wentzel, P., N. Welsh, and U. J. Eriksson. 1999. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes 48 (4):813–20. doi: 10.2337/diabetes.48.4.813.
PubMed Web of Science ®Google Scholar
Werner, E. F., P. Has, G. Tarabulsi, J. Lee, and A. Satin. 2016. Early postpartum glucose testing in women with gestational diabetes mellitus. Obstetrical & Gynecological Survey 71:697–699. doi: 10.1097/01.ogx.0000510809.66411.87.
Web of Science ®Google Scholar
White, D. 1973. The phospholipid composition of mammalian tissues. Form and Function of Phospholipids 441–82.
Google Scholar
Wilcox, R. A., W. U. Primrose, S. R. Nahorski, and R. A. J. Challiss. 1998. New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor. Trends in Pharmacological Sciences 19 (11):467–75. doi: 10.1016/S0165-6147(98)01260-7.
PubMed Web of Science ®Google Scholar
Williams, P. J., K. Gumaa, M. Scioscia, C. W. Redman, and T. W. Rademacher. 2007. Inositol phosphoglycan P-type in preeclampsia: a novel marker. Hypertension 49 (1):84–89. ? doi: 10.1161/01.HYP.0000251301.12357.ba.
PubMed Web of Science ®Google Scholar
Willmroth, F., T. Drieling, U. Lamla, M. Marcushen, H.-J. Wark, and D. Van Calker. 2007. Sodium-myo-inositol co-transporter (SMIT-1) mRNA is increased in neutrophils of patients with bipolar I disorder and down-regulated under treatment with mood stabilizers. The International Journal of Neuropsychopharmacology 10 (1):63–71. doi: 10.1017/S1461145705006371.
PubMed Web of Science ®Google Scholar
Witters, L., and B. Kemp. 1992. Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5'-AMP-activated protein kinase. The Journal of Biological Chemistry 267 (5):2864–7.
PubMed Web of Science ®Google Scholar
Wolfson, M., Y. Bersudsky, E. Zinger, M. Simkin, R. Belmaker, and L. Hertz. 2000. Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations. Brain Research 855 (1):158–61. doi: 10.1016/S0006-8993(99)02371-9.
PubMed Web of Science ®Google Scholar
Xie, P., L. Sun, P. J. Oates, S. K. Srivastava, and Y. S. Kanwar. 2010. Pathobiology of renal specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: Its implications in tubulo-interstitial fibrosis. American Journal of Physiology-Heart and Circulatory Physiology
Google Scholar
Yamashita, T., M. Tamatani, M. Taniguchi, T. Takagi, T. Yoshimine, and M. Tohyama. 1998. Regulation of Na+/myo-inositol cotransporter gene expression in hyperglycemic rat hippocampus. Brain Research. Molecular Brain Research 57 (1):167–72. doi: 10.1016/S0169-328X(98)00078-3.
PubMedGoogle Scholar
Yamazaki, H., K. C. Zawalich, and W. S. Zawalich. 2010. Physiologic implications of phosphoinositides and phospholipase C in the regulation of insulin secretion. Journal of Nutritional Science and Vitaminology 56 (1):1–8. doi: 10.3177/jnsv.56.1.
PubMed Web of Science ®Google Scholar
Yorek, M. A., J. A. Dunlap, and W. L. Lowe. 1998. Opposing effects of tumour necrosis factor α and hyperosmolarity on Na+/myo-inositol co-transporter mRNA levels and myo-inositol accumulation by 3T3-L1 adipocytes. Biochemical Journal 336 (2):317–25. doi: 10.1042/bj3360317.
PubMedGoogle Scholar
Yue, D. K., S. McLennan, E. Fisher, S. Heffernan, C. Capogreco, G. R. Ross, and J. R. Turtle. 1989. Ascorbic acid metabolism and polyol pathway in diabetes. Diabetes 38 (2):257–61. doi: 10.2337/diab.38.2.257.
PubMed Web of Science ®Google Scholar
Zeitler, P., and S. Handwerger. 1985. Arachidonic acid stimulates phosphoinositide hydrolysis and human placental lactogen release in an enriched fraction of placental cells. Molecular Pharmacology 28:549–554.
PubMed Web of Science ®Google Scholar
Zeitler, P., E. Markoff, and S. Handwerger. 1983. Characterization of the synthesis and release of human placental lactogen and human chorionic gonadotropin by an enriched population of dispersed placental cells. The Journal of Clinical Endocrinology and Metabolism 57 (4):812–818. doi: 10.1210/jcem-57-4-812.
PubMed Web of Science ®Google Scholar
Zeitler, P., Y. Q. Wu, and S. Handwerger. 1991. Melittin stimulates phosphoinositide hydrolysis and placental lactogen release: Arachidonic acid as a link between phospholipase A2 and phospholipase C signal-transduction pathways. Life Sciences 48 (21):2089–2095. doi: 10.1016/0024-3205(91)90166-9.
PubMed Web of Science ®Google Scholar
Zerbino, D. R., P. Achuthan, W. Akanni, M. R. Amode, D. Barrell, J. Bhai, K. Billis, C. Cummins, A. Gall, C. G. Girón, et al. 2018. Ensembl 2018. Nucleic Acids Research 46 (D1):D754–D761. doi: 10.1093/nar/gkx1098.
PubMed Web of Science ®Google Scholar
Zhan, M., I. M. Usman, L. Sun, and Y. S. Kanwar. 2015. Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease. Journal of the American Society of Nephrology : JASN 26 (6):1304–21. doi: 10.1681/ASN.2014050457.
PubMed Web of Science ®Google Scholar
Zhang, H., and C. Zhang. 2010. Adipose “talks” to distant organs to regulate insulin sensitivity and vascular function. Obesity (Silver Spring. Md) 18:2071.
PubMed Web of Science ®Google Scholar
Zhang, H., Y. Lv, Z. Li, L. Sun, and W. Guo. 2019. The efficacy of myo-inositol supplementation to prevent gestational diabetes onset: A meta-analysis of randomized controlled trials. The Journal of Maternal-Fetal & Neonatal Medicine32 (13):2249–2255. doi: 10.1080/14767058.2018.1428303.
PubMed Web of Science ®Google Scholar
Zheng, X., Z. Liu, Y. Zhang, Y. Lin, J. Song, L. Zheng, and S. Lin. 2015. Relationship between myo-inositol supplementary and gestational diabetes mellitus: A meta-analysis. Medicine 94 (42):e1604. doi: 10.1097/MD.0000000000001604.
PubMed Web of Science ®Google Scholar
Zhu, X., and J. Eichberg. 1990. A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes. Proceedings of the National Academy of Sciences 87 (24):9818–22. doi: 10.1073/pnas.87.24.9818.
PubMed Web of Science ®Google Scholar
Zhuo, Z.,. A. Wang, and H. Yu. 2014. Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis. Journal of Diabetes Research 2014:381231. doi: 10.1155/2014/381231.
PubMed Web of Science ®Google Scholar
Ziyadeh, F. N. 2004. Mediators of diabetic renal disease: The case for TGF-β as the major mediator. Journal of the American Society of Nephrology 15 (90010):55S–S57. doi: 10.1097/01.ASN.0000093460.24823.5B.
Google Scholar

A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date